Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
842 Cards in this Set
- Front
- Back
Recommended antibiotic: Exacerbations of chronic bronchitis
|
Amoxicillin or tetracycline or clarithromycin
|
|
Recommended antibiotic :Uncomplicated community-acquired pneumonia
|
Amoxicillin (Doxycycline or clarithromycin in penicillin allergic, add flucloxacillin if staphylococci suspected e.g. In influenza)
|
|
Recommended antibiotic : Pneumonia possibly caused by atypical pathogens
|
Clarithromycin
|
|
Recommended antibiotic :Lower urinary tract infection
|
Trimethoprim or nitrofurantoin. Alternative: amoxicillin or cephalosporin
|
|
Recommended antibiotic :Acute pyelonephritis
|
Broad-spectrum cephalosporin or quinolone
|
|
Recommended antibiotic :Acute prostatitis
|
Quinolone or trimethoprim
|
|
Recommended antibiotic :Impetigo
|
Topical fusidic acid, oral flucloxacillin or erythromycin if widespread
|
|
Recommended antibiotic :Cellulitis
|
Flucloxacillin (clarithromycin or clindomycin if penicillin-allergic)
|
|
Recommended antibiotic :Erysipelas
|
Phenoxymethylpenicillin (erythromycin if penicillin-allergic)
|
|
Recommended antibiotic :Animal or human bite
|
Co-amoxiclav (doxycycline + metronidazole if penicillin-allergic)
|
|
Recommended antibiotic :Throat infections
|
Phenoxymethylpenicillin (erythromycin alone if penicillin-allergic)
|
|
Recommended antibiotic :Sinusitis
|
Amoxicillin or doxycycline or erythromycin
|
|
Recommended antibiotic :Otitis media
|
Amoxicillin (erythromycin if penicillin-allergic)
|
|
Recommended antibiotic :Otitis externa*
|
Flucloxacillin (erythromycin if penicillin-allergic)
*a combined topical antibiotic and corticosteroid is generally used for mild/moderate cases of otitis externa |
|
Recommended antibiotic :Gonorrhoea
|
Cefixime or ciprofloxacin**
**there is actually now significant resistance to ciprofloxacin and other guidelines recommend cefixime 400mg PO (single dose) or ceftriaxone 250mg IM |
|
Recommended antibiotic :Pelvic inflammatory disease
|
Oral ofloxacin + oral metronidazole or intramuscular ceftriaxone + oral doxycycline + oral metronidazole
Benzathinebenzylpenicillin or doxycycline or erythromycin |
|
Recommended antibiotic :Syphilis
|
Benzathinebenzylpenicillin or doxycycline or erythromycin
|
|
Recommended antibiotic :Bacterial vaginosis
|
Oral or topical metronidazole or topical clindamycin
|
|
What causes chicken pox?
|
primary infection with varicella zoster virus
|
|
What is shingles?
|
is reactivation of dormant virus in dorsal root ganglion
|
|
How is chickenpox spread?
|
- respiratory route
- can be caught from someone with shingles |
|
What is the incubation period and infectivity of chickenpox?
|
• infectivity = 4 days before rash, until 5 days after the rash first appeared*
• incubation period = 10-21 days |
|
What are the clinical features of chickenpox?
|
• fever initially
• itchy, rash starting on head/trunk before spreading. Initially macular then papular then vesicular • systemic upset is usually mild |
|
What are the managents and advice given to patients with chickenpox?
|
• keep cool, trim nails
• calamine lotion • school exclusion: current HPA advice is 5 days from start of skin eruption. They also state 'Traditionally children have been excluded until all lesions are crusted. However, transmission has never been reported beyond the fifth day of the rash.' • immunocompromised patients and newborns with peripartum exposure should receive varicella zoster immunoglobulin (VZIG). If chickenpox develops then IV aciclovir should be considered |
|
What are the clinical complication of chickenpox?
|
A common complication is secondary bacterial infection of the lesions. Rare complications include
• pneumonia • encephalitis (cerebellar involvement may be seen) • disseminated haemorrhagic chickenpox • arthritis, nephritis and pancreatitis may very rarely be seen |
|
Define fetal varicella syndrome and its complications.
|
• risk of FVS following maternal varicella exposure is around 1% if occurs before 20 weeks gestation
• studies have shown a very small number of cases occurring between 20-28 weeks gestation and none following 28 weeks • features of FVS include skin scarring, eye defects (microphthalmia), limb hypoplasia, microcephaly and learning disabilities |
|
What is the management plan for preganancy women exposed to chickenpox?
|
• if there is any doubt about the mother previously having chickenpox maternal blood should be checked for varicella antibodies
• if the pregnant women is not immune to varicella she should be given varicella zoster immunoglobulin (VZIG) as soon as possible. RCOG and Greenbook guidelines suggest VZIG is effective up to 10 days post exposure • consensus guidelines suggest oral aciclovir should be given if pregnant women with chickenpox present within 24 hours of onset of the rash |
|
Organism causing chlamydia
|
Chlamydia trachomatis, an obligate intracellular pathogen
|
|
Clinical features of chlamydia
|
• asymptomatic in around 70% of women and 50% of men
• women: cervicitis (discharge, bleeding), dysuria • men: urethral discharge, dysuria |
|
Potential complication of chlamydia
|
• epididymitis
• pelvic inflammatory disease • endometritis • increased incidence of ectopic pregnancies • infertility • reactive arthritis • perihepatitis (Fitz-Hugh-Curtis syndrome) |
|
Approximately how young women in UK has chlamydia.
|
1/10
|
|
incubation period of chlamydia
|
7-21 days
|
|
Clostridium difficile and its complication
|
Gram positive rod often encountered in hospital practice. It produces an exotoxin which causes intestinal damage leading to a syndrome called pseudomembranous colitis.
|
|
How does clostridium difficile develop? and what medications cause it?
|
develops when the normal gut flora are suppressed by broad-spectrum antibiotics. Clindamycin is historically associated with causing Clostridium difficile but the aetiology has evolved significantly over the past 10 years. Second and third generation cephalosporins are now the leading cause of Clostridium difficile.
|
|
Clinical features of clostridium difficile
|
• diarrhoea
• abdominal pain • a raised white blood cell count is characteristic • if severe toxic megacolon may develop |
|
investigation of clostridium difficle
|
detecting Clostridium difficile toxin (CDT) in the stool
|
|
Management of clostridium difficile
|
• first-line therapy is oral metronidazole for 10-14 days
• if severe or not responding to metronidazole then oral vancomycin may be used • for life-threatening infections a combination of oral vancomycin and intravenous metronidazole should be used |
|
Definite traveller's diarrhoea
|
defined as at least 3 loose to watery stools in 24 hours with or without one of more of abdominal cramps, fever, nausea, vomiting or blood in the stool. The most common cause is Escherichia coli
|
|
clinical features of acute food poisoing.
|
sudden onset of nausea, vomiting and diarrhoea after the ingestion of a toxin.
|
|
3 organisims most commonly cause acute food poisoning
|
Staphylococcus aureus, Bacillus cereus or Clostridium perfringens.
|
|
Clinical features of :Escherichia coli
|
Common amongst travellers
Watery stools Abdominal cramps and nausea |
|
Clinical features of :Giardiasis
|
Prolonged, non-bloody diarrhoea
|
|
Clinical features of :Cholera
|
Profuse, watery diarrhoea
Severe dehydration resulting in weight loss Not common amongst travellers |
|
Clinical features of :Shigella
|
Bloody diarrhoea
Vomiting and abdominal pain |
|
Clinical features of :Staphylococcus aureus
|
Severe vomiting
Short incubation period |
|
Clinical features and complication of :Campylobacter
|
A flu-like prodrome is usually followed by crampy abdominal pains, fever and diarrhoea which may be bloody
Complications include Guillain-Barre syndrome |
|
Clinical features of Bacillus cereus
|
Two types of illness are seen
• vomiting within 6 hours, stereotypically due to rice • diarrhoeal illness occurring after 6 hours |
|
Clinical features of Amoebiasis
|
Gradual onset bloody diarrhoea, abdominal pain and tenderness which may last for several weeks
|
|
Acute food poisioning: incubation period of 1-6 hours
|
Staphylococcus aureus, Bacillus cereus*
*vomiting subtype, the diarrhoeal illness has an incubation period of 6-14 hours |
|
Acute food poisioning/ organisms: incubation period of •12-48 hrs
|
: Salmonella, Escherichia coli
|
|
Acute food poisioning/ organisms: incubation period of 48-72 hrs:
|
Shigella, Campylobacter
|
|
Acute food poisioning/ organisms: incubation period of 7 days
|
Giardiasis, Amoebiasis
|
|
alternative name for genital wart
|
condylomata accuminata
|
|
HPV causing gential wart
|
6 and 11
|
|
HPV causing cervical cancer
|
16, 18, 33
|
|
Clinical features of genital wart
|
• small (2 - 5 mm) fleshy protuberances which are slightly pigmented
• may bleed or itch |
|
Management of genital wart
|
• topicalpodophyllum or cryotherapy are commonly used as first-line treatments depending on the location and type of lesion. Multiple, non-keratinised warts are generally best treated with topical agents whereas solitary, keratinised warts respond better to cryotherapy
• imiquimod is a topical cream which is generally used second line • genital warts are often resistant to treatment and recurrence is common although the majority of anogenital infections with HPV clear without intervention within 1-2 years |
|
Organism causing gonorrhea
|
caused by the Gram negative diplococcus Neisseriagonorrhoea
|
|
Incubation period of gonorrhoea
|
2-5 days
|
|
Clinical features of gonorrhoea
|
Acute infection can occur on any mucous membrane surface, typically genitourinary but also rectum and pharynx
• males: urethral discharge, dysuria • females: cervicitis e.g. leading to vaginal discharge • rectal and pharyngeal infection is usually asymptomatic |
|
Clinical complications of gonorrhea
|
Local complications that may develop include urethral strictures, epididymitis and salpingitis (hence may lead to infertility). Disseminated infection and gonococall arthritis may occur
|
|
Management of gonorrhea
|
• ciprofloxacin 500mg PO used to be the treatment of choice
• however, there is increased resistance to ciprofloxacin and therefore cephalosporins are now used • options include cefixime 400mg PO (single dose) or ceftriaxone 250mg IM |
|
Define disseminated gonococcal infection
|
- gonococcal infection being the most common cause of septic arthritis in young adults.
- pathophysiology of DGI is not fully understood but is thought to be due to haematogenous spread from mucosal infection (e.g. Asymptomatic genital infection). |
|
Complication of of disseminated gonococcal infection
|
septic arthritis, endocarditis and perihepatitis (Fitz-Hugh-Curtis syndrome)
|
|
classical triad of disseminated gonoccal infection
|
• tenosynovitis
• migratory polyarthritis • dermatitis (lesions can be maculopapular or vesicular) |
|
Define H1N1
|
virus is a subtype of the influenza A virus and the most common cause of flu in humans. The 2009 pandemic was caused by a new strain of the H1N1 virus.
|
|
H1N1:particularly at risk groups
|
• patients with chronic illnesses and those on immunosuppressants
• pregnant women • young children under 5 years old |
|
Clinical features of H1N1 infection
|
The majority of symptoms are typical of those seen in a flu-like illness:
• fever greater than 38ºC • myalgia • lethargy • headache • rhinitis • sore throat • cough • diarrhoea and vomiting |
|
Complication of H1N1 infection
|
A minority of patients may go on to develop an acute respiratory distress syndrome which may require ventilatory support.
|
|
2 treatments of H1N1
|
Oseltamivir (Tamiflu)
Zanamivir (Relenza) |
|
What is Zanamivir (Relenza)
|
• inhaled medication*
• also a neuraminidase inhibitor • may induce bronchospasm in asthmatics *intravenous preparations are available for patients who are acutely unwell |
|
What is Oseltamivir (Tamiflu)
|
• oral medication
• a neuraminidase inhibitor which prevents new viral particles from being released by infected cells • common side-effects include nausea, vomiting, diarrhoea and headaches |
|
What is the incidence of HIV + women in london
|
0.4%
|
|
Factors reducing vertical transmission in HIV pregnancy
|
reduce vertical transmission (from 25-30% to 2%)
• maternal antiretroviral therapy • mode of delivery (caesarean section) • neonatal antiretroviral therapy • infant feeding (bottle feeding) |
|
What invesitgation should be screened for all pregnant women?
|
HIV
|
|
What are the factors that used to reduce HIV vertical transmission during pregancy? Explain each.
|
1 ) Antiretroviral therapy
• all pregnant women should be offered antiretroviral therapy regardless of whether they were taking it previously • if women are not currently taking antiretroviral therapy the RCOG recommend that it is commenced between 28 and 32 weeks of gestation and should be continued intrapartum. BHIVA recommend that antiretroviral therapy may be started at an earlier gestation depending upon the individual situation 2) Mode of delivery • elective caesarean section* • a zidovudine infusion should be started four hours before beginning the caesarean section 3) Neonatal antiretroviral therapy • zidovudine is usually administered orally to the neonate for four to six weeks 4) Infant feeding • in the UK all women should be advised not to breast feed *the 2008 BHIVA guidelines suggest vaginal delivery may be an option for women on HAART who have an undetectable viral load but whether this will translate into clinical practice remains to be seen |
|
Opportunistic organisms causing diarrhoea in HIV patients
|
• Cryptosporidium + other protozoa (most common)
• Cytomegalovirus • Mycobacterium aviumintracellulare • Giardia |
|
Explain role of crytosporidium in HIV + patients
|
the most common infective cause of diarrhoea in HIV patients. It is an intracellular protozoa and has an incubation period of 7 days. Presentation is very variable, ranging from mild to severe diarrhoea. A modified Ziehl-Neelsen stain (acid-fast stain) of the stool may reveal the characteristic red cysts of Cryptosporidium. Treatment is difficult, with the mainstay of management being supportive therapy*
|
|
Explain the role of Mycobacterium aviumintracellulare in HIV patients
|
Mycobacterium aviumintracellulare is an atypical mycobacteria seen with the CD4 count is below 50. Typical features include fever, sweats, abdominal pain and diarrhoea. There may be hepatomegaly and deranged LFTs. Diagnosis is made by blood cultures and bone marrow examination. Management is with rifabutin, ethambutol and clarithromycin
|
|
Which vaccines can be used in all HIV + adults?
|
Hepatitis A
Hepatitis B Haemophilusinfluenzae B (Hib) Influenza-parenteral Japanese encephalitis Meningococcus-MenC Meningococcus-ACWY I Pneumococcus-PPV23 Poliomyelitis-parenteral (IPV) Rabies Tetanus-Diphtheria (Td) |
|
What vaccines can be used in HIV + if CD4> 200
|
Measles, Mumps, Rubella (MMR)
Varicella Yellow Fever |
|
What vaccines are contraindicated in HIV + adults?
|
Cholera CVD103-HgR
Influenza-intranasal Poliomyelitis-oral (OPV) Tuberculosis (BCG) |
|
Management of oesophageal candidiasis in HIV + patients
|
Oesophageal candidiasis is the most common cause of oesophagitis in patients with HIV. It is generally seen in patients with a CD4 count of less than 100. Typical symptoms include dysphagia and odynophagia. Fluconazole and itraconazole are first-line treatments
|
|
Clinical features of HIV seroconversion
|
symptomatic in 60-80% of patients and typically presents as a glandular fever type illness. Increased symptomatic severity is associated with poorer long term prognosis. It typically occurs 3-12 weeks after infection
Features • sore throat • lymphadenopathy • malaise, myalgia, arthralgia • diarrhoea • maculopapular rash • mouth ulcers • rarely meningoencephalitis |
|
What investigations can be used to diagnosis HIV seroconversion?
|
• antibodies to HIV may not be present
• HIV PCR and p24 antigen tests can confirm diagnosis |
|
Define Hand, foot, mouth disease.
|
is a self-limiting condition affecting children. It is caused by the intestinal viruses of the Picornaviridae family (most commonly coxsackie A16 and enterovirus 71). It is very contagious and typically occurs in outbreaks at nursery
|
|
Clinical features of hand, foot, mouth disease.
|
• mild systemic upset: sore throat, fever
• oral ulcers • followed later by vesicles on the palms and soles of the feet |
|
Managment and advice of Hand foot and mouth disease
|
• general advice about hydration and analgesia
• reassurance no link to disease in cattle • children do not need to be excluded from school* *The HPA recommends that children who are unwell should be kept off school until they feel better. They also advise that you contact them if you suspect that there may be a large outbreak. |
|
Define head lice
|
Head lice (also known as pediculosiscapitis or 'nits') is a common condition in children caused by the parasitic insect Pediculuscapitis, which lives on and among the hair of the scalp of humans
|
|
Diagnosing headlice
|
• fine-toothed combing of wet or dry hair
|
|
Management of head lice
|
• treatment is only if living lice are found
• a choice of treatments should be offered - malathion, wet combing, dimeticone, isopropyl myristate and cyclomethicone School exclusion is not advised for children with head lice |
|
Define Hepatitis B
|
a double-stranded DNA virus and is spread through exposure to infected blood or body fluids, including vertical transmission from mother to child. The incubation period is 6-20 weeks.
|
|
What does hepatitis B vaccination contain?
|
• contains HBsAg adsorbed onto aluminium hydroxide adjuvant and is prepared from yeast cells using recombinant DNA technology
|
|
How often is hepatitis b vaccincation given?
|
• most schedules give 3 doses of the vaccine with a recommendation for a one-off booster 5 years following the initial primary vaccination
|
|
List the at risk groups who should have hepatitis b vaccination
|
healthcare workers, intravenous drug users, sex workers, close family contacts of an individual with hepatitis B, individuals receiving blood transfusions regularly, chronic kidney disease patients who may soon require renal replacement therapy, prisoners, chronic liver disease patients
|
|
What is the precentage of adults who fail to respond to hepatitis b vaccination? what are the risk factors?
|
• around 10-15% of adults fail to respond or respond poorly to 3 doses of the vaccine. Risk factors include age over 40 years, obesity, smoking, alcohol excess and immunosuppression
|
|
Which group of people should have testing for anti-Hbs?
|
only recommended for those at risk of occupational exposure (i.e. Healthcare workers) and patients with chronic kidney disease. In these patients anti-HBs levels should be checked 1-4 months after primary immunisation
|
|
Anti-Hbs level > 100mIU/ml
|
Indicates adequate response, no further testing required. Should still receive booster at 5 years
|
|
Anti-Hbs level 100 -10 mIU/ml
|
Suboptimal response - one additional vaccine dose should be given. If immunocompetent no further testing is required
|
|
Anti-Hbs level <10mIU/ml
|
Non-responder. Test for current or past infection. Give further vaccine course (i.e. 3 doses again) with testing following. If still fails to respond then HBIG would be required for protection if exposed to the virus
|
|
Complications of hepatitis B infection
|
• chronic hepatitis (5-10%)
• fulminant liver failure (1%) • hepatocellular carcinoma • glomerulonephritis • polyarteritisnodosa • cryoglobulinaemia |
|
Management of Hepatitis B
|
• pegylated interferon-alpha used to be the only treatment available. It reduces viral replication in up to 30% of chronic carriers. A better response is predicted by being female, < 50 years old, low HBV DNA levels, non-Asian, HIV negative, high degree of inflammation on liver biopsy
• however due to the side-effects of pegylated interferon it is now used less commonly in clinical practice. Oral antiviral medication is increasingly used with an aim to suppress viral replication (not in dissimilar way to treating HIV patients) examples include lamivudine, tenofovir and entecavir |
|
Managment of hepatitis B in pregnant women
|
• all pregnant women are offered screening for hepatitis B
• babies born to mothers who are chronically infected with hepatitis B or to mothers who've had acute hepatitis B during pregnancy should receive a complete course of vaccination + hepatitis B immunoglobulin • studies are currently evaluating the role of oral antiviral treatment (e.g. Lamivudine) in the latter part of pregnancy • there is little evidence to suggest caesarean section reduces vertical transmission |
|
Who are included in the human pailloma virus vaccination?
|
been introduced for girls aged 12-13 years. A number of catch-up programmes are being introduced for older girls.
|
|
Which vaccination is used in the HPV vaccination program and why?
|
Gardasil- protecting against HPV 16 & 18 it also protects against HPV 6 & 11 (genital warts)
* Cervarix only 16 and 18 |
|
When and how HPV vaccination are given?
|
For the vaccine to be effective it should be given before sexual activity starts. The vaccine is given as a series of three injections, usually within a 6-month period.
Injection site reactions are particularly common with HPV vaccines. |
|
Define infectious mononucleosis
|
caused by the Epstein-Barr virus (also known as human herpesvirus 4, HHV-4). It is most common in adolescents and young adults.
|
|
Clinical features of infectious mononucleosis
|
• sore throat
• lymphadenopathy • pyrexia • malaise, anorexia, headache • palatal petechiae • splenomegaly - occurs in around 50% of patients and may rarely predispose to splenic rupture • hepatitis • presence of 50% lymphocytes with at least 10% atypical lymphocytes • haemolyticanaemia • a maculopapular, pruritic rash develops in around 99% of patients who take ampicillin/amoxicillin whilst they have infectious mononucleosis |
|
Investigation of infectious mononucleosis
|
• heterophil antibody test (Monospot test)
|
|
Managment of infectious mononucleosis
|
• rest during the early stages, drink plenty of fluid, avoid alcohol
• simple analgesia for any aches or pains • consensus guidance in the UK is to avoid playing contact sports for 8 weeks after having glandular fever to reduce the risk of splenic rupture |
|
Background of influenza
|
- influenza season starts in middle of novemenber
- vaccination begins in sept to early november |
|
How many types of influenza virus?
|
There are three types of influenza virus; A, B and C. Types A and B account for the majority of clinical disease. Current vaccines are trivalent and consist of two subtypes of influenza A and one subtype of influenza B.
|
|
Which group of people should have annual influenza vaccination?
|
annual influenza vaccination for people older than 65 years and those older than 6 months
if they have: • chronic respiratory disease (including asthmatics who use inhaled steroids) • chronic heart disease (heart failure, ischaemic heart disease, including hypertension if associated with cardiac complications) • chronic kidney disease • chronic liver disease: cirrhosis, biliary atresia, chronic hepatitis • chronic neurological disease: (e.g. Stroke/TIAs) • diabetes mellitus (including diet controlled) • immunosuppression due to disease or treatment (e.g. HIV) • asplenia or splenic dysfunction • pregnant women Children in at risk groups should be vaccinated. Only children aged less than 9 years who have not received influenza vaccine before should receive a second dose of vaccine at least 4 weeks later. |
|
Which group of people at at risk of influenza and should be offered vaccination?
|
• health and social care staff directly involved in patient care (e.g. NHS staff)
• those living in long-stay residential care homes • carers of the elderly or disabled person whose welfare may be at risk if the carer becomes ill (at the GP's discretion) |
|
Background of influenza vaccine
|
• it is an inactivated vaccine, so cannot cause influenza. A minority of patients however develop fever and malaise which may last 1-2 days
• should be stored between +2 and +8�C and shielded from light • contraindications include hypersensitivity to egg protein. • in adults the vaccination is around 75% effective, although this figure decreases in the elderly • it takes around 10-14 days after immunisation before antibody levels are at protective levels |
|
Define leishmaniasis
|
caused by the intracellular protozoa Leishmania, usually being spread by sand flies. Cutaneous, mucocutaneousleishmaniasis and visceral forms are seen
|
|
Define Cutaneous leishmaniasis
|
• caused by Leishmaniatropica or Leishmaniamexicana
• crusted lesion at site of bite • may be underlying ulcer |
|
Define Mucocutaneousleishmaniasis
|
• caused by Leishmaniabrasiliensis
• skin lesions may spread to involve mucosae of nose, pharynx etc |
|
Define Visceral leishmaniasis (kala-azar)
|
• mostly caused by Leishmaniadonovani
• occurs Mediterranean, Asia, South America, Africa • fever, sweats, rigors • massive splenomegaly. hepatomegaly • poor appetite*, weight loss • grey skin - 'kala-azar' means black sickness • pancytopaenia secondary to hypersplenism *occasionally patients may report increased appetite with paradoxical weight loss |
|
Define leoptospirosis
|
Also known as Weil's disease*, leptospirosis is commonly seen in questions referring to sewage workers, farmers, vets or people who work in abattoir. It is caused by the spirochaeteLeptospirainterrogans (serogroup L icterohaemorrhagiae), classically being spread by contact with infected rat urine.
|
|
Define weil's disease
|
Weil's disease should always be considered in high-risk patients with hepatorenal failure
*the term Weil's disease is sometimes reserved for the most severe 10% of cases that are associated with jaundice |
|
Clinical features of leptospirosis
|
• fever
• flu-like symptoms • renal failure (seen in 50% of patients) • jaundice • subconjunctivalhaemorrhage • headache, may herald the onset of meningitis |
|
MRSA stands for
|
Methicillin-resistant Staphylococcus aureus (MRSA) was one of the first organisms which highlighted the dangers of hospital-acquired infections
|
|
Who should be screened for MRSA?
|
• all patients awaiting elective admissions (exceptions include day patients having terminations of pregnancy and ophthalmic surgery. Patients admitted to mental health trusts are also excluded)
• from 2011 all emergency admissions will be screened |
|
How should a patient be screened for MRSA?
|
• nasal swab and skin lesions or wounds
• the swab should be wiped around the inside rim of a patient's nose for 5 seconds • the microbiology form must be labelled 'MRSA screen' |
|
How can MRSA be suppressed in carriers once identified?
|
• nose: mupirocin 2% in white soft paraffin, tds for 5 days
• skin: chlorhexidinegluconate, od for 5 days. Apply all over but particularly to the axilla, groin and perineum |
|
Which antibiotics are used to treat MRSA?
|
• vancomycin
• teicoplanin |
|
Which antibiotics maybe sensitive but they are generally not used alone because of resistance may develop?
|
• rifampicin
• macrolides • tetracyclines • aminoglycosides • clindamycin |
|
Which new antibiotic can be used in treatment of MRSA but reserved for resistant cases?
|
linezolid, quinupristin/dalfopristin combinations and tigecycline
|
|
How many cases of malaria cases each year in the UK of patients returning from endemic country?
|
1500-2000 cases, majority not taking prophylaxis
|
|
What protozoa and % cause majority of malaria cases in the UK?
|
Plasmodium falciparum
75% |
|
What happens to the innate immunity when move to the Uk from area of high endemic?
|
lost their immunity!
|
|
Side effects, Start time and end time of malaria prophylaxis: Atovaquone + proguanil (Malarone)
|
GI upset,
Start: 1-2 days End: 7 days |
|
Side effects, Start time and end time of malaria prophylaxis: Doxycycline
|
Side effect: Phtosensitivity, oesophagitis
Start time: 1-2 days End time: 4 weeks |
|
Side effects, Start time and end time of malaria prophylaxis:Chloroquine
|
Side effect: Headache
Start time: 1 week End time: 4 week Contraindicated in epilepsy Taken weekly |
|
Side effects, Start time and end time of malaria prophylaxis:Mefloquine (Lariam)
|
Side effect: Dizziness, Neuropsychiatric disturbance
Start time: 2-3 weeks End time: 4 weeks Contraindicated in epilepsy Taken weekly |
|
Side effects, Start time and end time of malaria prophylaxis: Proguanil (Paludrine), Proguanil + chloroquine
|
Side effect: GI upset, Headache
Start time:1 week End time: 4 weeks |
|
What are the medical advice and medication for pregnant women travelling to malaria regions?
|
advised to avoid travelling to regions where malaria is endemic. Diagnosis can also be difficult as parasites may not be detectable in the blood film due to placental sequestration. However, if travel cannot be avoided:
• chloroquine can be taken • proguanil: folate supplementation (5mg od) should be given • Malarone (atovaquone + proguanil): the BNF advises to avoid these drugs unless essential. If taken then folate supplementation should be given • mefloquine: caution advised • doxycycline is contraindicated |
|
What are the medical advice and medication for children travelling to malaria regions?
|
avoid travel to malaria endemic regions with children if avoidable. However, if travel is essential then children should take malarial prophylaxis as they are more at risk of serious complications.
• diethyltoluamide (DEET) 20-50% can be used in children over 2 months of age doxycycline is only licensed in the UK for children over the age of 12 years |
|
What investigation should be performed for suspected menigitis?
|
• full blood count
• CRP • coagulation screen • blood culture • whole-blood PCR • blood glucose • blood gas Lumbar puncture if no signs of raised intracranial pressure |
|
Management in GP of patient with suspected meningococcal disease.
|
IM benzypenivillin in GP then admit
|
|
Suspected menigitis antibiotic treatment: aged < 3 months
|
Intravenous cefotaxime + amoxicillin
|
|
Suspected menigitis antibiotic treatment: aged 3 months - 50 years
|
Intravenous cefotaxime
|
|
Suspected menigitis antibiotic treatment: aged > 50 years
|
Intravenous cefotaxime + amoxicillin
|
|
Antibiotic treatment for Meningococcal meningitis
|
Intravenous benzylpenicillin or cefotaxime
|
|
Antibiotic treatment for Pneuomococcal meningitis
|
Intravenous cefotaxime
|
|
Antibiotic treatment for Meningitis caused by Haemophilusinfluenzae
|
Intravenous cefotaxime
|
|
Meningitis caused by Listeria
|
Intravenous amoxicillin + gentamicin
|
|
Which antibiotic to give to patients with suspsected penicillin allergy or cephalosporin?
|
chloramphenicol.
|
|
How to manage the contact of confirmed/suspsected menigitis?
|
• prophylaxis needs to be offered to household and close contacts of patients affected with meningococcal meningitis
• oral rifampicin or ciprofloxacin may be used • the risk is highest in the first 7 days but persists for at least 4 weeks • meningococcal vaccination should be offered when serotype results are available, for close contacts who have not previously been vaccinated |
|
What are the complications of mycoplasma pneumoniae infection?
|
• cold agglutins (IgM) may cause an haemolyticanaemia, thrombocytopenia
• erythema multiforme, erythema nodosum • meningoencephalitis, Guillain-Barre syndrome • bullous myringitis: painful vesicles on the tympanic membrane • pericarditis/myocarditis • gastrointestinal: hepatitis, pancreatitis • renal: acute glomerulonephritis |
|
What does mycoplasma pneumoniae cause?
|
atypical pneumonia which often affects younger patients
|
|
How many years does epidemic of mycoplama pneumoniae classically happen?
|
Every 4 years
|
|
Clinical features of mycoplasma pneumoniae.
|
• the disease typically has a prolonged and gradual onset
• flu-like symptoms classically precede a dry cough • bilateral consolidation on x-ray • complications may occur as below |
|
Investigation of mycoplasma pneumoniae
|
• diagnosis is generally by Mycoplasma serology
• positive cold agglutination test |
|
Managment of mycoplasma pneumoniae
|
• erythromycin/clarithromycin
tetracyclines such as doxycycline are an alternative |
|
List the UK urgent notifiable diseases
|
- Anthrax
- Cholera - Diphtheria - acute infectious hepatitis - Measles - Meningitis - Meningococcal septicaemia - Plague - Poliomyelitis - Rabies - Invassive group A streptocococcal disease (No to Scarlet fever) - Smallpox - SARS - botulium - Enteric fever ( typhoid or parathyphoid) -Viral haemorrhagic fever, including Lassa fever and Marburg virus - Whooping cough ( acute phase) - Haemolytic uraemic syndrome - infectious bloody diarrhoea - legionnaires' disease |
|
List of UK non urgent nortifiable diseases
|
Acute encephalitis
Brucellosis ( unless thought UK acquired_ Food poisoning ( unless clusters) Leprosy Malaria (unless UK acquired) Mumps Tetanus TB ( unless HCW, clusters, multi drug resistance) Typhus Yellow fever ( unless UK aquired Scarlet fever |
|
How many pneumococal vaccines are currently available?
|
• pneumococcal conjugate vaccine (PCV)
• pneumococcal polysaccharide vaccine (PPV) |
|
When is the PCV vaccination given to children?
|
as part of their routine immunisations (at 2, 4 and 13 months).
|
|
Which group of patients should be vaccinated against pneumococcal infection?
|
• asplenia or splenic dysfunction
• all adults over the age of 65 years • splenectomy • chronic respiratory disease: COPD, bronchiectasis, cystic fibrosis, interstitial lung disease. *Asthma is only included if 'it requires the use of oral steroids at a dose sufficient to act as a significant immunosuppressant' • chronic heart disease: ischaemic heart disease if requiring medication or follow-up, heart failure, congenital heart disease. *Controlled hypertension is not an indication for vaccination • chronic kidney disease • chronic liver disease: including cirrhosis and chronic hepatitis • diabetes mellitus if requiring medication • immunosuppression (either due to disease or treatment). This includes patients with any stage of HIV infection • cochlear implants • patients with cerebrospinal fluid leaks |
|
How many does of pneumococcal vaccine does an adult receive?
|
1
|
|
Which group of patients should have pneumococcal booster every 5 years?
|
asplenia, splenic dysfunction or chronic kidney disease
|
|
What organisms cause community acquired pneumonia?
|
• Streptococcus pneumoniae (accounts for around 80% of cases) - commonest
• Haemophilus influenzae • Staphylococcus aureus: commonly after the 'flu • atypical pneumonias (e.g. Due to Mycoplasma pneumoniae) • viruses • Klebsiella pneumoniae is classically in alcoholics |
|
What are the clinical features of pneumococcal pneumonia?
|
• rapid onset
• high fever • pleuritic chest pain • herpes labialis What the BTS recommended treatment for CAP? • low or moderate severity CAP: oral amoxicillin. A macrolide should be added for patients admitted to hospital • high severity CAP: intravenous co-amoxiclav + clarithromycin OR cefuroxime + clarithromycin OR cefotaxime + clarithromycin |
|
Post-exposure prophylaxis: Hepatitis A
|
• Human Normal Immunoglobulin (HNIG) or hepatitis A vaccine may be used depending on the clinical situation
|
|
Post-exposure prophylaxis: Hepatitis B
|
• HBsAg positive source: if the person exposed is a known responder to HBV vaccine then a booster dose should be given. If they are in the process of being vaccinated or are a non-responder they need to have hepatitis B immune globulin (HBIG) and the vaccine
• • unknown source: for known responders the green book advises considering a booster dose of HBV vaccine. For known non-responders HBIG + vaccine should be given whilst those in the process of being vaccinated should have an accelerated course of HBV vaccine |
|
Post-exposure prophylaxis: Hepatitis c
|
• monthly PCR - if seroconversion then interferon +/- ribavirin
|
|
Post-exposure prophylaxis: HIV
|
• a combination of oral antiretrovirals (e.g. Tenofovir, emtricitabine, lopinavir and ritonavir) as soon as possible (i.e. Within 1-2 hours, but may be started up to 72 hours following exposure) for 4 weeks
• serological testing at 12 weeks following completion of post-exposure prophylaxis • reduces risk of transmission by 80% |
|
Post-exposure prophylaxis: Varicella Zoster
|
• VZIG for IgG negative pregnant women/immunosuppressed
|
|
What is the estimated transmission risk of hepatitis B after single needlestick injury ?
|
20-30%
|
|
What is the estimated transmission risk of hepatitis C after single needlestick injury ?
|
0.5-2%
|
|
What is the estimated transmission risk of HIV after single needlestick injury ?
|
0.3%
|
|
Explain quinolone and give 2 examples.
|
Quinolones are a group of antibiotics which work by inhibiting DNA synthesis and are bactericidal in nature. Examples include:
• ciprofloxacin • levofloxacin |
|
What is the mechanism of action of quinolones?
|
• inhibit topoisomeras II (DNA gyrase) and topoisomerase IV
|
|
What are the side effect of quinolones?
|
• lower seizure threshold in patients with epilepsy
• tendon damage (including rupture) - the risk is increased in patients also taking steroids • cartilage damage has been demonstrated in animal models and for this reason quinolones are generally avoided (but not necessarily contraindicated) in children |
|
In what group of patients where a no antibiotic prescribing or delayed antibiotic prescribing approach is generally recommended?
|
acute otitis media, acute sore throat/acute pharyngitis/acute tonsillitis, common cold, acute rhinosinusitis or acute cough/acute bronchitis
|
|
In what group of patients is an immediate antibiotic prescribing approach may be considered for?
|
• children younger than 2 years with bilateral acute otitis media
• children with otorrhoea who have acute otitis media • patients with acute sore throat/acute pharyngitis/acute tonsillitis when 3 or more Centor criteria are present |
|
What is the centor criteria?
|
• presence of tonsillar exudate
• tender anterior cervical lymphadenopathy or lymphadenitis • history of fever • absence of cough |
|
Which group of patients at risk of developing complications, an immediate antibiotic prescribing policy is recommended for?
|
• are systemically very unwell
• have symptoms and signs suggestive of serious illness and/or complications (particularly pneumonia, mastoiditis, peritonsillar abscess, peritonsillar cellulitis, intraorbital or intracranial complications) • are at high risk of serious complications because of pre-existing comorbidity. This includes patients with significant heart, lung, renal, liver or neuromuscular disease, immunosuppression, cystic fibrosis, and young children who were born prematurely • are older than 65 years with acute cough and two or more of the following, or older than 80 years with acute cough and one or more of the following: • - hospitalisation in previous year • - type 1 or type 2 diabetes • - history of congestive heart failure • - current use of oral glucocorticoids |
|
How long does an acute otitis media last for?
|
4days
|
|
How long does acute sore throat/acute pharyngitis/acute tonsillitis last for?
|
1 week
|
|
How long does common cold last for?
|
1.5 week
|
|
How long does acute rhinosinusitis last for?
|
2.5weeks
|
|
How long does acute cough/acute bronchitis last for?
|
3 weeks
|
|
How many criteria are present for there to be a sore throat caused of Group A beta haemolytic streptococcus? And what percentage?
|
if 3 or more of the criteria are present there is a 40-60% chance the sore throat is caused by Group A beta-haemolytic Streptococcus
|
|
What are the differentials of genital ulcers?
|
Genital herpes, syphilis, chanroid, lymphogranuloma venereum, Behcet's disease,carcinoma
, granuloma inguinale: Klebsiella granulomatis* |
|
Which organism cause chancroid?
|
is a tropical disease caused by Haemophilus ducreyi
|
|
How does chancroid normally present?
|
causes painful genital ulcers associated with unilateral, painful inguinal lymph node enlargement. The ulcers typically have a sharply defined, ragged, undermined border.
|
|
Definite Lymphogranuloma venereum
|
caused by Chlamydia trachomatis.
Typically infection comprises of three stages • stage 1: small painless pustule which later forms an ulcer • stage 2: painful inguinal lymphadenopathy • stage 3: proctocolitis |
|
School exclusion advice: no exclusion
|
Conjunctivitis
Fifth disease Roseola Infectious mononucleosis Head lice Threadworms |
|
School exclusion advice: 24 hours after commencing antibiotics
|
Scarlet fever
|
|
School exclusion advice: Four days from onset of rash
|
Measles
|
|
School exclusion advice: Chickenpox
|
Five days from onset of rash
|
|
School exclusion advice: Mumps
|
Five days from onset of swollen glands
|
|
School exclusion advice: Whooping cough
|
Five days after commencing antibiotics
|
|
School exclusion advice: Rubella
|
Six days from onset of rash
|
|
School exclusion advice: Diarrhoea & vomiting
|
Until symptoms have settled for 48 hours
|
|
School exclusion advice: Impetigo
|
Until lesions have crusted over
|
|
School exclusion advice: Scabies
|
Until treated
|
|
School exclusion advice: Influenza
|
Until recovered
|
|
Which organism cause syphilis?
|
caused by the spirochaete Treponema pallidum
|
|
How many stages do syphilis present?
|
3 stages:
Primary • chancre - painless ulcer at the site of sexual contact • local non-tender lymphadenopathy • often not seen in women (the lesion may be on the cervix) • A painless ulcer (chancre) is seen in the primary stage. Secondary (occurs 6-10 weeks after primary infection) • systemic symptoms: fevers, lymphadenopathy • rash on trunk, palms and soles • buccal 'snail track' ulcers (30%) • condylomata lata Tertiary stages/latent period • gummas • aortic aneurysms • general paralysis of the insane • tabes dorsalis |
|
What is the incubation period of syphilis?
|
incubation period= 9-90 days
|
|
What are the clinical features of congenital syphilis?
|
• blunted upper incisor teeth
• keratitis • saber shins • saddle nose • deafness |
|
What is tetanus vaccine?
|
a cell-free purified toxin that is normally given as part of a combined vaccine.#
|
|
When is tetanus vaccine is currently given in the UK as part of the routine immunisation schedule?
|
• 2 months
• 3 months • 4 months • 3-5 years • 13-18 years This therefore provides 5 doses of tetanus-containing vaccine. Five doses is now considered to provide adequate long-term protection against tetanus. |
|
When should tetanus immunoglobulin to given?
|
Intramuscular human tetanus immunoglobulin should be given to patients with high-risk wounds (e.g. Compound fractures, delayed surgical intervention, significant degree of devitalised tissue) irrespective of whether 5 doses of tetanus vaccine have previously been given
If vaccination history is incomplete or unknown then a dose of tetanus vaccine should be given combined with intramuscular human tetanus immunoglobulin for high-risk wounds |
|
Rifampicin: side effect and MOA
|
Rifampicin: side effect and MOA
|
|
Isoniazid : side effect and MOA
|
• mechanism of action: inhibits mycolic acid synthesis
• peripheral neuropathy: prevent with pyridoxine (Vitamin B6) • hepatitis, agranulocytosis • liver enzyme inhibitor |
|
Pyrazinamide: side effect andMOA
|
• mechanism of action: converted by pyrazinamidase into pyrazinoic acid which in turn inhibits fatty acid synthase (FAS) I
• hyperuricaemia causing gout • hepatitis |
|
Ethambutol:side effect and MOA
|
• mechanism of action: inhibits the enzyme arabinosyl transferase which polymerizes arabinose into arabinan
• optic neuritis: check visual acuity before and during treatment • dose needs adjusting in patients with renal impairment |
|
What is the standard treatment regime of active TB?
|
Initial phase - first 2 months (RIPE)
• Rifampicin • Isoniazid • Pyrazinamide • Ethambutol (the 2006 NICE guidelines now recommend giving a 'fourth drug' such as ethambutol routinely - previously this was only added if drug-resistant tuberculosis was suspected) Continuation phase - next 4 months • Rifampicin • Isoniazid |
|
What is the treatment regime of latent TB?
|
isoniazid alone for 6 months
|
|
How long should meningeal TB be treated for?
|
a prolonged period (at least 12 months) of standard therapy with the addition of steroids
|
|
Which group of patients should have directly observed therapy with a three times a week dosing regimen of TB medications?
|
• homeless people with active tuberculosis
• patients who are likely to have poor concordance • all prisoners with active or latent tuberculosis |
|
Explain mantoux test and its interpertation
|
• main technique used to screen for latent tuberculosis.
• ml of 1:1,000 purified protein derivative (PPD) injected intradermally • result read 2-3 days later In recent years the interferon-gamma blood test has also been introduced. It is used in a number of specific situations such as: • the Mantoux test is positive or equivocal • people where a tuberculin test may be falsely negative (see below) Mantoux test result: <6mm Negative - no significant hypersensitivity to tuberculin protein Previously unvaccinated individuals may be given the BCG Mantoux test result: 6-15 mm Positive - hypersensitive to tuberculin protein Should not be given BCG. May be due to previous TB infection or BCG Mantoux test result: > 15 mm Strongly positive - strongly hypersensitive to tuberculin protein Suggests tuberculosis infection. |
|
What group of patients may have false negative mantoux test ?
|
• miliary TB
• sarcoidosis • HIV • lymphoma • very young age (e.g. < 6 months) |
|
What is the treatment guideline of UTI in non pregnant women?
|
trimethoprim or nitrofurantoin for 3 days
|
|
What is the treatment guideline of UTI in pregnant women?
|
For symptomatic bacteriuria should be treated with an antibiotic for 7 days. A urine culture should be sent.
For asymptomatic pregnant women: • a urine culture should be performed routinely at the first antenatal visit • if positive, a second urine culture should be sent to confirm the presence of bacteriuria • SIGN recommend to treat asymptomatic bacteriuria detected during pregnancy with an antibiotic • a 7 day course of antibiotics should be given • a further urine culture should be sent following completion of treatment as a test of cure |
|
What is the treatment of acute pyelonephritis
|
- hospital admission should be considered
- a broad-spectrum cephalosporin or a quinolone for 10-14 days or co-amoxiclav |
|
Describe Acanthosis nigricans
|
symmetrical, brown, velvety plaquest that are often found in the axilla, groin, and neck
|
|
What are the causes of acanthosis nigicans?
|
• gastrointestinal cancer
• diabetes mellitus • obesity • polycystic ovarian syndrome • acromegaly • Cushing's disease • hypothyroidism • familial • Prader-Willi syndrome • drugs: oral contraceptive pill, nicotinic acid |
|
Define acne rosacea.
|
a chronic skin inflammatory disease of unknown cause
, older patients (30-50), more females |
|
Clinical features of acne roasesa
|
Typically affects the nose/cheek/ forehead
Transient erythema (flushing) with burning sensation is common Telangiectasia is common Persistant erythema can cause papules and pustules Rhinophyma ( red nose) Blepharitis |
|
Management of acne rosacea
|
1) Topical metronidazole ( mild disease)
2) Oral metronidazole, oxytetracycline, erythromycin 3) Camouflage cream 4) High SFF 5) Laser therapy( prominent telangiectasia) 6) Avoid steriod 7) Avoid exacerbating factors ( heat, cold, wind, sun, stress, drinking hot liquid, alcohol, caffiene, spices ) |
|
Define Acne Vulgaris
|
- A common inflammatory disease of pilosebaceous follicles caused by keratin plugs.
- Increased sebum production which is converted to FFA by anearobic propionibacterium acne --> irritant causing inflammation and delayed hypersensitivity causing papules, comdeones, and pustules - affecting mostly adolescence ( 80-90%, with 60 % seeking help) - Adults > 25y: 10-15% female, 5% male |
|
Exacerbating factors of Acne vulgaris
|
menstruation/ hormonal factors ( androgen increases sebum production )
OCP Topical acngenic agents ( steroids, taqrs, ointments, greasy cometics ) Systemic meds: lithium, phenytoin, steroids, halogens, androgens, iodides, bromides, danzol |
|
How many types of Acne Vulagris are there?
|
4 types:
1) Type 1 (mild)- comedones ( dilated sebaceous follicles, Open- black head, closed- white heads) 2) Type 2 (moderate)- papules ( inflammatory lesions form and follicles bursts and release irritant ) +/- scarring 3) Type 3 ( Moderate)- pustular ( as above) + scarring 4) Type 4 (Severe) -nodules and cysts ( excessive inflammatory response) + severe scarring |
|
What is characteristic about drug induced acne?
|
monomorphic appearance
|
|
What type of acne does steroid induced acne cause?
|
pustules
|
|
What is acne fulminans?
|
Severe acne with systemic upset. Ususally require hospitalization and responds to steroid.
|
|
What is the treatment of acne vulgaris?
|
1) mild - topical single therapy ( Topical retinoids, BZP )
2) moderate - topical combination therapy ( topical abx erythromycin/clindamycin, BZP, topical retinoid - retinion) 3) severe - oral antibiotics ( oxytetracycline, doxycycline, trimethoprim, erythromycin-safe in pregana, tetracycline ) 4) very severe- oral isotretinion ( unsafe in pregnancy and breastfeeding) * COCP can also be used- dianette * oral treatment takes 3-4 months to see effect * no role of dietary modication in patients with acne |
|
Why is minocycline less used in the management of acne vulgaris?
|
potentially causes irreversible pigementation
|
|
What is a potential complication of long term antibiotic use in acne vulagris? Whats the treatment?
|
gram negative follicultis, can be treated with oral trimethoprim
|
|
Define actinic keratoses (aka. solar keratoses)
|
a common premalignant skin lesions that develops as result of chronc sun exposure
more common in elderly more males 1-10% can transform to SCC |
|
What is the Sx of actinic keratoses?
|
Normally found in sun exposed areas
small crusty scaly pink/brown/flesh coloured lesions |
|
What are the management of actinic keratoses?
|
1) Advice: avoid sun, SPF
2) Fluorouracil cream : 2-3 weeks course, can cause inflammation of skin, which can be treated with topical hydrocortisone 3) Topical diclofenac ( mild disease, moderate efficacy but few side effects) 4) Topical imiquimoid (Aldara) applied for 8-10 weeks 5) Cryotherapy 6) Curettage and cautery * biopsy lesions that are resistant to treatment. |
|
How many types of allergy testing?
|
Skin prick test
Radioallergosorbent rest (RAST) Skin patch testing |
|
Explain skin prick test
|
commonest because easy to perform, quick 15mins to read, and inexpensive
Procedure: skin pricked with needles, diluted allergen applied, wheal develops if allergic and compared to control (sterile water) Useful for food allergies and pollen |
|
Explain RAST testing
|
Useful for food allergies, inhaled allergen (eg. pollen), and wasp/bee venom
Results graded from 0 ( negative) to 6 ( strong) Determines amount of IgE in blood that reacts to specific known or suspected allergen used when skin prick test unsuitable (eg. extensive ezcema or patient taking antihistamine) |
|
Explain skin patch testing
|
Useful for contact dermatiis
30-40 allergens and irritants placed on the back --> removed 48 hours later, read by dermatologist |
|
What causes scarring alopecia (ie. destruction of hair follicle?
|
Trauma/burn
radiotherapy lichen planus discoid lupus untreated tinea capitis --> kerion |
|
What causes non scarring alopecia ( ie. preservation of hair follicles ) ?
|
Male pattern baldness
tchicotillomania telogen effluvium ( hair loss following stressful event) autoimmune ( alopecia areata) Fe/zinc deficiency Rx: COCP, colchichine, heparin, carbimazole, cytotoxic drugs |
|
Define alopecia areata.
|
autoimmune condition characterized by patches of complete hair loss ( localised , well demarcated ) localized to scalp, eyebrowns, beard, eyelashes
If hair loss is at hairline, there maybe "exclamation mark" pattern. |
|
How long does patient with alopecia areata take to regrow hair without treatment?
|
50% regrows at 1 y, 80-90% grows eventually
* worse prognosis if young and extensive losses * frequent recurrence that can be precipated by emotional distress |
|
What are the treatment options for patients with alopecia areata?
|
1) reassurance
2) Wigs 3) Topical or intralesional corticosterioids 4) Topical minoxidil 5) phototherapy 6) dithranol 7) contact immunotherapy * treatments are usually unsatisfactory |
|
Define antiphospholipid (antibody) syndrome.
|
an not understood acquired disorder that causes an increased risk of venous and aterial thromboses formation.
It can be a primary condition or secondary condition It is associated with SLE, autoimmune diseases, lymphoproliferative disorders, phenothiazine (rare) |
|
What lab investigations can be done for patient with suspected antiphospholipid syndrome?
|
Anticardiolipin and lupus anticoagulant antibodies
|
|
What are the features associated with antiphsopholipid syndrome?
|
Venous/aterial thrombosis
recurrent spontaneous fetal loss thombocyctopenia prolonged APPT ( but ex vivo reation of lupus anticoagulant autoantibodies with phsopholips results in transient paradoxical rise in APTT) livedo reticularis (purplish mottling of the skin) pre-eclampsia pulmonary hypertension |
|
What is the anticoagulation management of patients with antiphospholid syndrome?
|
Arterial thrombosis (INR 2-3) and recurrent venous thrombosis (INR 3-4) - lifelong warfarin
Initial venous thrombosis (INR 2-3)- 6/12 warfarin |
|
Explain Athele's foot ( aka: tinea pedis) .
|
Fungal infection of the foot caused by Trichophyton
|
|
What are the clinical features of tinea pedis ( athlete's foot)?
|
typically scaling, flaking, itching between toes
exacerbated by heat, humidity, occlusive footwear |
|
What is the treatment for tinea pedis?
|
First line : Topical imidazole ( clotrimazole 1%, 2% miconazole) , undecenoate ( Mycota) , terbinafine
|
|
Explain Basal Cell Carcinoma.
|
maligant proleration of basal cells of the epidermis
one of the 3 main types of skin cancer commonest skin cancer in the western world There are 4 subtypes but most common is nodular BCC Lesions are also known as rodent ulcers characterized by slow growth and local invasion Mets are extremely rare More male |
|
What are the causes of BCC?
|
scar formation, radiation, trauma, arsenic exposure, genetic predisposition ( Gorlin syndrome)
Most commonly sun exposure |
|
What are the clinical features of basal cell carcinoma?
|
normally over sun exposed area ( eg. head and neck)
initially pearly, flesh-coloured papule with telangiectasia which may ulcerate leaving a central crater. |
|
What are the treatment options fo basal cell carcinoma?
|
1) topical cream if surgery not appropriate: imiquimod, fluorouracil
2) Radiotherapy 3) cryotherapy 4) curettage 5) surgical removal * lifelong follow up *95% cure rate if lesion is less than 2cm |
|
Define blepharitis.
|
inflammation of the eyelid margins
|
|
What are the causes of blepharitis?
|
1) Posterior blephritis (Common) : meibomian gland dysfunction
2) Anterior blephritis ( uncommon ): seborrhoeic dermatitis, staphylococcal infection * more common with acne rosacea patients |
|
What are the clinical features and complications of blephritis?
|
usually bilateral
sticky morning eyes grittness and discomfort red and swollen ( esp,. staphylococcal blepharitis) Complications: styes and chalazion, secondary conunctivitis, keratitis, corneal ulveration and neovascularization |
|
Why does meibomian dysfunction causes blephritis?
|
meibomian glands secretes oil onto eye surface--> prevent tears film evaporating rapidly T4 if lack --> drys eyes and irritation.
|
|
What is the management plan for blepharitis?
|
1) softening of lid margins using hot compression BD
2) Mechanical removal of debris from lid margin with diluated baby shampoo (4:1 with cooled boil water). Can also use sodium bicarbonate. 3) Artificial tears 4) topical and systemic abx +/- referral ? steroid. |
|
Explain bowen's disease.
|
Aka: SCC in situ
more common in female 3% chance of developing into invasive skin cancer |
|
Clinical features of bowen's disease
|
red, scaly patches with sharply demarcated red and scaly border
often found in the lower limbs |
|
Treatment options fo bowen's disease
|
1) biopsy for diagnosis
2) as per BCC, topical cream if surgery not appropriate: imiquimod, fluorouracil Radiotherapy cryotherapy curettage surgical removal |
|
What are the causes of bullous skin disorders?
|
• congenital: epidermolysis bullosa
• autoimmune: bullous pemphigoid, pemphigus • insect bite • trauma/friction • drugs: barbiturates, furosemide |
|
Define bullous pemphigoid.
|
a chronice autoimmune skin condition causing sub-epidermal blistering of skin. ( ie. IgG antibodies againist hemidesmosomal protien at dermal-erpidermal basement membrane)
Elderly female most common |
|
Clinical features of bullous pemphigoid
|
itchy, tense blisters typically around flexures
mouth usually spared ( 10-50% patient with involvement) blisters heal without scarring |
|
How is bullous pemphigoid diagnosed ( ie. invesgation ) ?
|
skin biopsy: immunofluorescence shows IgG and C3 at basement membrane
blood test: anti-basement membrane antibodies (IgG) |
|
Management of bullous pemphigoid.
|
1) referral to dermatologist
2) oral steroid +/- azathioprine 3) Topical steroid ( ie . clobetasol ) 4) Topical antibiotic ( tetracycline +/- nicotinamide) 5) dapsone ( mild cases) |
|
Management of cellulitis.
|
1) flucloxacillin oral ( mild/moderate) or clarithromycin/clindamycin (if pen allergic)
2) oral clindamycin if fail to responds to flucloxacillin 3) IV benpen ( severe) + admit |
|
Define cherry haemangioma ( aka: campbell demorgan spot).
|
benign vacular neoplasm/lesion
abnormal proliferation of capillaries Male=female more elderly can increase in size |
|
Clinical features and treatment of cherry haemangioma.
|
dome shaped erythmatous papule
1-3 mm in size non blanching not found on mucous membrane NO treatment needed ( comestic: laser or excision) |
|
Define chondrodematitis nodularis helicis.
|
common and begnin
characterized by development of painful nodule on ear usually secondary to friction, cold, trauma and persistent pressure ( eg. headset) More men Elderly |
|
Management of chondrodermatitis nodularis helicis.
|
1) reducing pressure
2) ear protectors 3) surgical- but with high recurrence 4) cyrotherapy, steroid injfection, collagen injection. |
|
Define contact dermatitis and how many types?
|
cutaneous inflammation between interaction of external agent and skin. There are 2 types: 1) allergic contact dermatitis 2) irritant contact dermatitis
|
|
Explain/Sx/Mx irritant contact dermatitis.
|
non immune mediated
irritant to skin ( weak acids or alkalis-detergent) comon, esp amongst hand erythema ( common) crusting/ vesicles (rare) Mx: avoidance, moisturiers, topical +/- oral steroids |
|
Explain/Sx/Mx allergic contact dermatitis.
|
immune cell mediated type 4 hypersentivity
uncommon Eg. hair dye Presents with weeping eczema Mx: patch testing, avoidance, topical steroid +/- oral steroid |
|
What material can cause allergic contact dermatitis and irritant contact dermatitis?
|
cement!
Alkaline nature-irriatnt dichromates in cement- allergic |
|
Explain dermatitis herpetiformis
|
Autoimmune blistering skin disorder.
Deposition of IgA in dermis Associated with coeliac disease (80%), thyroid disease, intestinal lymphoma, iron and folate deficiency |
|
Sx of dermatitis herpetiformis.
|
intensely itchy grounped of papules, vesicles, urticarial wheals on extensor surfaces of skin ( eg. elbow, knee, buttocks)
Bilateral symmetrical almost always excoriated, rarely blisters |
|
What is seen on skin biopsy for dermatitis herpetitformis?
|
direct immunofluorescence - deposition of IgA in granular pattern in the upper dermis
|
|
Mx for dermatitis herpetiformis
|
Gluten free diet
dapsone for itch |
|
Explain dermatomyositis
|
idopathic or associated with CTD or underlying malignancy ( eg. lung cancer- about 20-25%, more if older)
an inflammatory disorder causing symmetrical, proximal muscle weakness, and characteristic skin lesions. |
|
What is the name of the condition that is similar to dermatomyositis but skin manifestiation isn't prominent?
|
polymyositis
|
|
Clinical features of dermatomyositis.
|
Photosensitive
Macular rash over back and shoulder Nail fold capillary dilatation Heliotrope rash-in periorbital region ( red rash) Gottron's papules - roughenged red papules over extensor surfaces of fingers. |
|
What are the associated features systemic complications of dermatomyositis?
|
proximal muscle weakness +/- tenderness
Raynaud's Respiratory muscle weakness interstitial lung disease ( fibrosising alveolitis or organising pneumonia) Dysphagia and dyphonia |
|
What drugs causes photosensitivity?
|
Amiodarone
Doxycycline, tetracycline, sulphonamide, ciprofloxacin Thiazides NSAID ( eg. piroxicam) Sulphonylureas Psoralens |
|
What is ezcema herpeticum?
|
occurs in patients with severe atopic ezcema and infected with HSV 1/2
Hospitalization and IV aciclovir |
|
Define and explain atopic ezcema.
|
an acute and chornic inflammation of the skin
IgE mediated ( Type 1 hypersensitivity) |
|
How many children in the UK has atopic ezcema? How many % clear for 5 and how many clear by 10?
|
15-30%
by 5y- 50% by 10y-75 % |
|
What is the clinical features of atopic eczema? infant? younger children? older children/adult?
|
Infant (2-6m): face, scalp, trunk
Younger children: extensor surfaces Older children/adults: flexures surfaces and creases of face/neck |
|
What is the treatment options for atopic eczema?
|
1) Avoid irritant
2) Abundance of emollient ( 250 gram/week, cream soaks better then ointments, BD) 3) Topical steroids- applied 30 mins after emollients 4) Severe cases- wet wraps/ oral ciclosporin/steroids, topical immunomodulators- pimecrolimus and tacrolimus ( safe for face and neck) * topical0 fuscidic acid /oral antibiotics- cephalexin, antiseptic body waters dermol 500. |
|
What is the UK working Party diagnostic criteria for atopic ezcema?
|
any itchy skin condition in the last 12 months + 3 or more of the following
1) visible flexural dermatitis 2) PmHX of atopic dsease ( or if under 4y, first degree relative with atopic disease) 3) history of dry skin 4) history of flexural involvement ( or if under 18m, dermatitis on cheeks+/- extensor areas) 5) onset below age of 2y ( not used if child is under 4y) |
|
List the mild topical steroids.
|
Hydrocortisone 0.5-2.5%
|
|
List the moderate topical steroid
|
betamethasone valerate 0.025% ( Betnovate RD)
clobestasone butyrate 0.05% ( Eurmovate) |
|
List the potent topical steroids
|
FLuticasone propionate 0.05% ( Cutivate)
Betamethasone valerate 0.1% ( Betonovate) |
|
List the very potent topical steroid.
|
Clobestasol priopionate 0.05% (Dermovate)
|
|
Define erythema ab igne and explain its clinical features and managment
|
a skin disorder that occurs due to prolonged exposure to infared radiation
commonly seen in elderly women sitting beside a heater/open fire Sx: retiuclated, erythematous patches with hyperpigmentation and telangiectasia. Can develop into SCC treated via avoidance, if not better then biopsy +/- 5-fluorouracil cream , topical tretinoin or laser |
|
Define erythema multiforme and its clinical features.
|
a skin disorder that cause be caused by many things.
Presents with target "bull eyed" lesions, bilateral symmetrical macules/papules with central vesicles all lesions appear with 3 days Initially on back of hands/feet before spreading to torso Upper limbs more affected than lower limbs Pruitius weakness malasie |
|
List the causes of erythema multiforme
|
idiopathic
Viruses: HSV ( commonest), Orf ( skin disease of sheep/goat caused by parapox virus) Bacteria: mycoplasma and streptococcus, histoplasma capsulatum rx: penicillin, sulphonamides, carbamazepine, allopurinol, NSAIDs, COCP, nevirapine Disease: sarcoidosis, malignancy, CTD- SLE. |
|
Mx of erythema multiforme
|
1) symptomatic treatment ( oral antihistamines)
2) ? steriod if unwell ( controversial) * usually heals without complications within 2 weeks |
|
Define and explain erythema nodosum.
|
acute or chronic inflammation of subcutanesous fat ( aka: panniculitis)
|
|
Clinical features of erythema nodosum
|
tender, erythematous, round, poorly demarcated nodular lesions
usually over shin, but can be anywhere ( thigh, arms) usually resolves with 6 weeks lesions heal without scarring more female assocaited arthralgia, fever, malaise asymmetrical |
|
Causes of erythema nodosum.
|
NO (no causes in 40%) D- drugs ( sulfonamides, OCP, penicillin) S- sarcodisis U- ulcerative colitis and Crohn's (More C than U), Malignancy ( leukaemia, hodgkin's, lymphoma)
Infection: streptococci, TB, brucellosis, Bechcet's disease Pregnancy |
|
Investigation of eyrthema nodosum
|
CXR- ? chest infection ? sarcoidosis
throat culture Antistreptolysin test |
|
Managment of erythema nodosum
|
1) symptomatic : bed rest, compressive bandages, wet dressing
2) NSAID 3) treat underlying |
|
What is the definition of erythroderma? what are its causes?
|
it is a generalised term used when there are more than 95% of the skin involvement in any kind of rashes.
Causes: idiopathic eczema psoriasis lymphoma and leukaemia Rx: gold |
|
What is erythromdermic psoriasis?
|
Its a condition when a chonic skin condition progress to an exfoliative phase with plaque conver most of the body. (eg. acute withdrawal of steroid)
Associated with systemic upset Hospitalised |
|
What causes fungal nail infection (aka: onychomycosis) ?
|
dermatophytes- mainly trichophyton rumbrum ( accounts for 90% of cases)
yeasts- candida non-dermatophyte moulds |
|
How does onychomycosis present?
|
unsightly nails that are thickened, rough, opaque
|
|
How to diagnose onychomycosis?
|
nail clipping, scarping of affected nails.
|
|
What are the treatment options of onychomycosis?
|
1) investigated first before treatment
2) candida infection- topical antifungal for mild disease ( amorolfine) or oral itraconazole for severe disease for 3 months 3) dermatophyte infection- first line oral terbinafine, alternative itraconazole. Fingers- 6 wks to 3 months and toes- 3 m to 6m. * treatment only successful in 50 -80% of patients. |
|
What is geographic tongue? How does it present? Treatment?
|
a benign, chronic condition of the tongue of an unknown cause.
more in female looks like a map on tongue ( erythematous smooth areas with irregular border) 1-3% of population Mx: reassurance Can present with burning tongue after eating |
|
What is granuloma annulare?
|
papular lesions that are often slightly hyperpigmented and depressed centrally
usually asymptomatic typicaly on dorsal of surfaces of hands and feets, extensor aspects of arms and legs ? weak link to diabetes mellitus |
|
What is Kaposi sarcoma thats related to HIV? Complication? Management? Presentation?
|
It is causes by Human herpes virus 8
it usually presents with purple papules or plaques on skin or mucosa (eg. GI and resp) which may ulcerate Complication: respiratory involvement causing massive haemoptysis and pleural effusion Management: radiotherapy and resection |
|
What is hereditary haemorrhagic telangiectasia?
|
Aka: Osler-Weber- Rendu sundrome
Autosomal dominant or idiopathic ( 20%) Presents with multiple telangiectasia over skin and mucosa |
|
What is the diagnostic criteria for hereditary haemorrhagic telangiectasia?
|
There are 4 main diagnostic criteria ( more than 3 definite, 2 is possible)
1) telangiectases: multiple at characteristic site ( lips, oral cavity, fingers, nose) 2) Visceral lesions: ateriovenous malformation ( pulmonary, hepatic, cerebral, spinal ) and GI telangiectasia ( with/without bleeding) 3) positive first relative family history 4) recurrent/spontanesous nose bleeds ( epistaxis) |
|
Explain HSV.
|
There are 2 types: HSV 1 ( coldsore) and HSV ( genital herpes). There is overlap.
Painful vesicular grouped lesions. |
|
How does a patient with HSV infection present and its management?
|
cold sore ( topical aciclovir)
severe gingivostomatitis ( oral aciclovir, chlorhexidine MW) painful genital ulceration ( oral aciclovir ) |
|
What is herpes zoster and its treatment.
|
Aka: shingles
reactivation of varicella zoster virus--> acute painful blistering in the same dermatome managed with oral aciclovir |
|
Definition of hirsutism
|
describes androgen dependent hair growth in women
|
|
Definition of hypertrichosis
|
describes androgen independent hair growth in women
|
|
What causes hypertrichosis?
|
Anorexia nervosa
porphyria cutanea tarda congenital hypertrichosis lanuginosa congenital hypertrichosis terminalis Rx: minoxidil, ciclosporin, diazoxide |
|
Whats causes hirsutism?
|
PCOS
Cushing's syndrome Congential adrenal hyperplasia androgen therapy Obesity ( because peripheral conversion of oestrogens to androgens) adrenal tumor androgen secreting ovarian tumor Rx: phenytoin |
|
What scoring system is used to assess hirsutism?
|
Ferriman-gallwey scoring system: body divided into 9 parts and scored out of 4, > 15 is moderate/severe hirsutism.
|
|
How can hirsutism be managed?
|
1) advise weight loss if high BMI
2) aesthetic management ( laser, wax etc) 3) facial hirsutim ( topical elfornithine- contraindicated in pregnancy and breastfeeding) 4) COCP ( eg. dianette- co-cyprindiol or Yasmin- ethinylestradiol and drospirenone ). Not for long term use. |
|
What is hyperhidrosis?
|
term to describe excessive sweating
|
|
What are the treatment options fo hypertrichosis?
|
1) topical aluminium- first line, but can cause skin irritation
2) iontophresis- plates, particularly useful for palmar, plantar and axillary hyperhidrosis 3) botox injection- currently liscensed for axillary symptoms 4) surgery - ( eg. endoscopic transthoracic sypathectomy)- but at risk of over compensatory sweating post procedure. |
|
What is xanthomata?
|
- deposition of yellowish cholesterol-rich material.
- cutaneous manifestations of lipidosis in which there is an accumulation of lipids in large foam cells within the skin |
|
In which condition can you see palmar xanthoma?
|
remnant hyperlipidaemia
familial hypercholesterolaemia ( less common) |
|
What are eurptive xanthoma?
|
presents as multiple red/yellow vesicles on the extensor surfaces ( eg. elbows, knees) secondary to high triglyceride level
|
|
What causes eruptive xanthoma?
|
familial hypertriglyceridaemia
lipoprotien lipase deficiency |
|
Out of tendon xanthoma ( yellow) , tuberous xanthoma, xanthelasma ( eyes), which one can be seen in patients without lipid abnormalitis
|
xanthelasma
|
|
Which condition is associated with tendon xanthoma, tuberous xanthoma, xanthelasma?
|
familial hypercholesterolaemia
remnant hyperlipidaemia |
|
What are the management options of xanthelasma?
|
1) electrodesiccation
2) laser therapy 3) topical trichloroacetic acid 4) surgical excision |
|
What is the Gell and coombs classication of hypersensitivity?
|
type 1- anaphyalctic
type 2- cell bound type 3- immune complex type 4- delayed hypersensitivity type 5- stimulated hypersensitivity |
|
Explain and give examples of type 1- anaphyalctic
|
IgE bound to mast cells and antigen reacts with it
Eg: anapylaxis an atopy |
|
Explain and give examples of type 2 cell bound
|
IgG and IgM binds to antigen on cell surface
Eg: autoimmune haemolytic anaemia, ITP, Good pasture's |
|
Explain and give examples of type 3 immune complex
|
fee atigen and antibody (IgG and IgA) combine
Eg. serum sickness, SLE, post streptococcal glomerulonephritis, extrinsic allergic alveolitis ( esp, during acute phase) |
|
Explain and give examples of type 4 delayed hypersensitivity
|
T cell mediated
Eg. TB, tuberculin skin reaction, graft versus hot disease, allergic contact dermatitis, scabies, extrinsic allergic alveolitis ( es, chronic phase) |
|
Explain and give examples of type 5 stimulated hypersensitivity
|
IgG antibodies stimulate cells they are directed against
Eg. Grave's disease, myasthenia gravis |
|
Define impetigo vulgaris and its presentation.
|
acute purulent infection
Vesicular--> golden yellow honey crusted lesions with surrounding erythema face,arms, legs, buttocks young school children |
|
What causes impetigo vulgaris?
|
GroupA B haemolytic streptococcus, S. aureus
|
|
How to treat impetigo vulgaris?
|
1) localised disease
- remove crust - topical mupirocin or fusdic acid ( first line) 2) extensive disease - oral flucloxacillin - oral erythromycin ( if pen allergic) |
|
What are the side effects of oral isotretinoin?
|
1) hair thinning
2)dry skin, eyes, lips ( commonest), nasal mucosa ( nosebleeds) 3)low mood 4)benign intracranial HTN ( not to be given with tetracycline,which will worsen symptoms) 5) raised triglycerides 6) teratogenicity (should ideally be using 2 forms of contraception eg. COCP and condomes) * 2/3 of patients have long term remission or cure of severe acne following a course of oral isotretinoin |
|
What are keloid scars?
|
- they are tumour like lesions tha arise from the connective tissue of a scar and extend beyond the healed wound site
|
|
What are the predisposing factors of keloid scars?
|
1) more common in young than old
2) ethnicity ( eg. people with darker skin) 3) common sites: - sternum ( most) - shoulder - neck -face - extensor surgace of limbs - truck ( least) * keloid scarsare less likely along langerlines ( ie. along relaxed skin tension lines) |
|
What is keratocanthoma?
|
benign epithelial neoplasm with atypical keratinocytes in epidermis
middle age, but not increase number in age |
|
What is kertocanthoma associated with?
|
HPV, UV radiation, chemical carcinogen ( tar and mineral oil)
|
|
Which skin cancer does keratocanthoma look like?
|
SCC therefore remove urgently
|
|
What are the clinical features of keratoacanthoma?
|
erupting "volcano " lesion
initially smooth dome shaped papule--> rapidly grows and become a crater centrally filled with keratin ( usually over 6 weeks) - spontaneous regression within 3 months is common - often resulting in disfiguring scar - usually found in sun exposed skin - tender |
|
What is lentigo maligna?
|
- a type of melanoma in situ ( ie. normal and maligant melanocytes confined to epidermis)
- pre malignant lesion - progresses slowly-->eventually become lentigo maligna melanoma ( 15% of all melanomas) |
|
What is leukoplakia?
|
- commonest oral premalignant condition
- white hard spot/plaque on the oral mucous membranes ( doesn't rub off) - strongly associated with tobacoo use and alcohol consumption - M>F - peak at 50 |
|
What are the differential of leukoplakia?
|
candidiasis and lichen planus, oral hairy leukoplakia
|
|
Once leukoplakia is diagnosed, what is the investigation performed and why ?
|
- Biopsy because premalignant lesion and exclude SCC
- regular follow up is required to exclude malignant transformation to SCC ( 1% of patients) |
|
What is lichen planus?
|
- an acute or chronic inflammtory skin/mucosa condition of unknown aetiology, most likely immune mediated
- characterized by violaceous papules, esp on flexural surfaces |
|
What is lichen planus associated with and what can trigger it?
|
- associated with hepatitis C
- can be triggered by severe emotional distress |
|
Which medications cause lichenoid drug eruptions?
|
gold, quinine, thiazide
|
|
What are the clinical features of lichem planus?
|
- intensely itchy flat topped shiny papular rash
- resolves with hyperpigmented macules - rash are often polygonal in shape with a white-lace pattern on surface ( aka: Wickham's striae) -sites: wrists, ankles, genitalia, nails, scalp, mucous membranes ( mouth/vulva/glans) - nails: longitudinal ridging, dystrophic - mucous membrane: lacy,whitish reticular network, milky white ( 50% of patients) |
|
What phenomenon is associated with lichen planus?
|
Koebner phenomenon following trauma
|
|
What is the treatment of lichen planus?
|
1) topical corticosteroids ( mainstay)
2) extensive may require oral steroids or immunosuppression 3) photochemotherapy for generalised or resistant cases 4) oral retinoids for erosive lesion in mouth |
|
What is lichen sclerosus?
|
inflammatory condition of the skin
ususally found in elderly female affecting genitalia leads to atrophy of the epidermis with white plaques forming |
|
What is the prominent clinical feature of lichen sclerosus?
|
itch!
|
|
How is lichen sclerosus usually invesitgated? why?
|
- biopsy to exclude other diagnoses
- increased risk of vulval cancer |
|
What is the main stay management of lichen sclerosus?
|
topical steroids and emollients
|
|
What is lyme disease?
|
- spread by ticks
- caused by the spirochaete Borrelia burgdorferi |
|
What are the clinical features of lyme disease?
|
Early: erythema chronicum migrans ( widespread area of surrounding erythema) + fever + arthralgia
CVS: heart block, myocarditis Neuro: cranial nerve palsies, meningitis |
|
What is the investigation for lyme disease?
|
blood test: antibodies to Borrelia burgdorfei
|
|
What is the management of lyme disease?
|
early disease ( doxycycline)
disseminated disease ( ceftriaxone) |
|
What is Jarisch-Herxheimer reaction?
|
patient presents with fever, rash, tachycardia after first dose antibiotic
most commonly seen in syphillis- spirochaetal disease |
|
What is the breslow thickness and 5 year survival for malignant melanoma?
|
- measures the invasion depth of a tumour
- single most important factor in determine prognosis < 1mm (95-100%) 1-2 mm ( 80-96%) 2.1-4 mm ( 60-75%) >4 mm ( 50%) |
|
What is melasma ( aka: chloasma)?
|
a hyperpigmented macular skin condition in sun exposed area, particularly around face
|
|
What causes the development of melasma?
|
Pregnancy and COCP
|
|
Who is are risk of developing melasma?
|
women and dark skin people
|
|
What is milia?
|
- small benign keratin filled cyts
- typically on face - any age but more new born |
|
What is molluscum contagiosum?
|
highly infectious skin condition caused by DNA pox virus
|
|
What is the characteristic rash of molluscum contagiosum?
|
small, dome like, pearly, umbilicated lesions
|
|
What are the treatment options of mollusum contagiosum?
|
1) conversative ( esp. early phrase as begnin)- usually resolve within 1 year
2) avoid direct contact with others to prevent spread 3) surgical ( aldara, curettage, cryotherapy, topical cantharidin) |
|
What type of hypersensitivity reaction is nickle reaction?
|
It is an allergic contact dermatitis ie. type 4 hypersensitivity reaction
|
|
What is onycholysis?
|
seperation of nail plate from nail bed
|
|
What causes onycholysis?
|
-idiopathic
- trauma ( eg. excessive manicuring) - infection ( esp. fungal ) - skin disease ( psoriasis, dermatitis ) - impaired peripheral circulation ( PVD, Raynaud's) - Hyper and hypo thyroidism |
|
What orf?
|
- skin lesion found in sheep and goats but can be transmitted to humans.
- caused by parapox virus |
|
What is the clinical presentation of orf in humans?
|
initially small, raised, red-blue papules ---> grow to 2-3 cm and become flat topped and haemorrhagic
usually self limiting disease |
|
What is the clinical features of pemphigus vulgaris?
|
-presenting symptoms with mucosal ulceration ( 50-60% pt) then skin lesions over 6-12 months
-heals with hyperpigmentation but no scars |
|
What is pemphigus vulgaris?
|
- autoimmune blistering disease
- more common amongst mediterranean, asian, Jewish population |
|
Describe the rash of pemphigus vulgaris.
|
- painful, easily rupture, flaccid, non-pruritic epidermal bullae/vesicles on an erythematous or normal skin base
- superficial bullae as compared to bullous pemphigus |
|
What is the pathophysiology of pemphigus vulgaris? skin biopsy?
|
- IgG antibodies directed against epidermal desmoglein 3 leading to intraepidermal bullae
- skin biopsy shows acantholysis ( ie. loss of intracellular connection), immunoflurescence shows IgG and C3 deposition intraepidermally. |
|
which conditions are pemphigus vulgaris associated with?
|
thymoma, myasthenia gravis, malignancy, use of D-penicillamine
|
|
What is the Nikolsky's sign of pemphigus vulgaris?
|
sliding and rubbing pressure on skin causes the seperation of epidermis (ie. spread of bullae)
|
|
What is the treatment option of pemphigus vulgaris?
|
1) prednisolone until no new blisters
2) immunosuppressant |
|
What is pityriasis versicolor?
|
-aka: tinea versicolor
-superficial cutaneous fungal infection caused by malassezia furfur |
|
What are the predisposing factors to pityriasis versicolor?
|
-none
- immunosuppression - malnutrition - cushing's |
|
What are the clinical features of pityriasis versicolor?
|
-area of hypopigmentation, pink or brown patches
- mostly affecting trunk -scale - mild pruritus |
|
What are the treatment options of pityriasis versicolor?
|
1) topical antifungal ( terbinafine or selenium sulphide)
2) extensive disease ( oral itraconazole) |
|
What is pompholyx?
|
- aka: dyshidrotic dermatitis
- a type of ezcema that affects both hands (cheiropompholyx) and feet ( pedopompholyx) |
|
What are the clinical features of pompholyx?
|
pruritic small blisters forming on palms and soles --> burst--> dry and cracked
|
|
What are the treatments for pompholyx?
|
- cool compression
- emollient - topical steroid + wrap - intralesional triamcinoclone - oral steroid in severe cases |
|
What is porphyria cutanea tarda?
|
-inherited defect in uroporphyrinogen decarboxylase OR
caused by hepatocyte damage secondary to alcohol and oestrogens - commonest hepatic porphyria |
|
What are the clinical features of porphyria cutanea tarda?
|
- commonest- photosensitive rash with blistering and skin fragility on face/ dorsal aspect of hands
- hypertrichosis ( abnormal hair overgrowth) - hyperpigmentation |
|
What the porphyria cutanea tarda investigated?
|
urine- elevated uroporphyrinogen and pink flourescence of urine under Wood's lamp
|
|
How is porlyria cutanea tarda treated?
|
chloroquine and venesection
|
|
What are at risk of developing pressure ulcers?
|
- lack of mobility ( age, paralysis, body illness, pain )
- malnourishment - incontinence - elderly |
|
Where does pressure usually develop?
|
over bony prominences ( sacrum/heel)
|
|
How many gradings are there of the European Pressure Ulcer Advisory Panel criteria?
|
4 grades
|
|
What is European Pressure Ulcer Advisory Panel criteria grade 1?
|
- non - blanchable erythema of intact skin
- indicators : discolouration of skin, warmth, induration, hardness ( particluarly useful in darker skin) |
|
What is European Pressure Ulcer Advisory Panel criteria grade 2?
|
- abrasion or blister, superficial ulcer
- partical thickness skin loss involving epidermis or dermis or both |
|
What is European Pressure Ulcer Advisory Panel criteria grade 3?
|
- full thickness skin loss
- damage to or necrosis of subcutaneous tissue that extend ( not through) underlying fascia |
|
What is the European Pressure Ulcer Advisory Panel criteria grade 4?
|
- extensive destruction
- tissue necrosis -damage to muscle/bone/supporting structure -with or without full skin loss |
|
What is the management plan for a patient with pressure ulcer?
|
1) referral to tissue viability nurse
2) consider referral for surgical debridement 3) hydrocolloid dressing and hydrogels- promote ulcer healing in a moist enviroment * dont use soap * would swab shouldn't be routinely done useless look infected ( ie. with surround erythema) |
|
What are the 5 conditions that most commonly cause pruritus?
|
1) Liver disease
2) Iron deficiency anaemia 3) Polycythaemia 4) Chronic kidney disease 5) lymphoma |
|
What other conditions cause pruritus?
|
Hyper-/hypo thyrodism
Diabetes Pregnancy "senile" pruritus urticaria Skin disorder: eczema, scabies, psoriasus, pityriasis roasea |
|
What is pyoderma gangrenosum?
|
a condition that causes small red papule then becoming deep,red, necrotic ulcers with violaceous border
|
|
What are the clinical features of pyoferma gangrenosum?
|
- typically affecting the lower limbs
- maybe with systemic upset ( eg. myalgia and fever) |
|
What conditions are associated with pyoderma gangrenosum?
|
- idiopathic in 50% of cases
- IBD ( UC, Crohn's) - RA - SLE - myeloproliferative disorders - lymphoma - leukaemias - primary biliary cirrhosis - monoclonal gammapathy (IgA) - DM II (rare) |
|
What are the treatments of pyoderma gangrenosum?
|
Rapid progression therefore steroid asap
consider other immunosupressants ( eg. ciclosporin or infliximab) |
|
What is pyogenic granuloma?
|
it is a common benign skin lesion.
|
|
What conditions are associated with pyogenic granuloma?
|
Trauma
Pregnancy |
|
What are the clinical features of pyrogenic granuloma?
|
- more common in young adults and female
- small red/brown spot--> raised red/brown spherican lesions +/- bleeding and ulcerating ( over days to weeks) - common site: head/neck, upper trunk, and hands, oral mucosa ( particularly in pregnancy) |
|
What is the treatment option with pyogenic granuloma?
|
1) normally resolves post partum
2) curettage and cauterisation 3) cryotherapy 4) excision |
|
What is reactive arthritis?
|
-one of the HLA-B27 associated seronegative spondyloarthopathies.
- an arthritis that develop following an infection where the organism can't not isolated in the joint fluid. |
|
What is reiter's sydrome?
|
- Post STI
- classic triad of urethritis, conjunctivitis, arthritis |
|
What are the clinical features of reactive arthritis/Reiter's syndrome?
|
-asymmetrical oiligoarthritis of lower limbs
- dactylitis - urethritis - conjunctivitis (50%), anterior uveitis - Skin: circinate balanitis (painless vesicles on the coronal margin of prepuce), keratoderma, blenorrhagica ( waxy yellow/brown papules on palms and soles) * 25% develop recurrent episodes * 10% develop chronic disease * typically develops over 4 weeks from initial infection * above symptoms can last for 4-6 months |
|
What is scabies?
|
-caused by parasite mite Sarcoptes scabiei
-mite burrows into the skin and laying its eggs in stratum corneum - transmitted via contact |
|
What are the clinical features of scabies?
|
- incubation : intensely widespread itch after 1 month from initial infection
- linear burrows on sides of finger, interdigital webs and flexor aspect of wrist, usually sparing od head and neck ( except infants) - prone to secondary infection because of excoriation and infection - can remain itchy for 4 -6 weeks after clearing infection ( prolonged hypersensitvity) |
|
What type of hypersensitvitiy reaction is scabies infection?
|
Type 4 delayed reaction to mites and effects
|
|
What is the management plan for a patient who has been infected with scabie?
|
1) avoid lose physical contact until all contacts treated, even if asymptomatic
2) wash all clothing, bedding etc at 40c because mites can remain alive 2-3 days on them 3) permethrin 5% (first line) - apply to dry skin, left on whole body for 8-12 hours, repeat 1 week 4) malathion 0.5% ( second line) -left on 24 hrs, repeat 1 week later 5) antihistamine |
|
Whatis seborrhoeic dermatitis?
|
thought to be caused by inflammatory reaction to proliferation of normal skin fungus inhabitant known as malassezia furfur
|
|
How many % of the general population is affected by seborrhoeic dermatitis?
|
2 %
|
|
What kind of problems does seborrhoeic dermatitis cause? Adult and children.
|
- eczematous lesion on sebum rich areas: scalp ( dandruff), periorbital, auricular, chest, nasolabial folds, +/- otitis externa and blepharitis
- greasy, erythematous, yellow, non pruritic scaling papules, plaques - Children: cradle cap, nappy area, face and limb flexures |
|
What is cradle cap?
|
seborric dermatitis in scalp of babies.
normally develop in first few weeks of life erythematous rash with coarse yellow scales tends to spontaneously resolve by 8 months |
|
What is the management of cradle cap and seborhoeic dermatitis in children?
|
1) mild -moderate ( baby shampoo, baby oil)
2) severe- mild topical steroids ( eg 1 % hydrocortisone) |
|
What conditions are seborrheic dermatitis associated with?
|
-immunocompromised patients ( eg. HIV)
- Parkinson's disease |
|
What is the scalp management of seborrheic dermatitis in adult?
|
First line ( zinc pyrithione- Head & shoulder) or ( tar ( Neutrogena T gel)
second line ketoconazole Selenium sulphide and topical corticosteroid maybe useful |
|
What is the body and face treatment for an adult with seborrheic dermatitis?
|
Difficult to treat. recurrence common.
1) Topical antifungal ( Ketoconazole) 2) Topical steroids ( short term) |
|
What is seborrhoeic keratoses?
|
benign epidermal skin lesion seen in elderly patients
autosomal dominant |
|
What are the clinical features of seborrhoeic keratoses?
|
-Large variation in colour ( flesh to light brown)
- stuck on appearance - may look warty over time |
|
What is the management of seborrhoeic keratoses?
|
Reassurance as benign
comestic: curettage, cryosurgery, shave biopsy |
|
What are the differential for shin lesions?
|
Erythema nodosum
pretibial myxoedema pyoderma gangrenosum necrobiosis lipoidica diabeticorum |
|
What is pretibial myxoedema?
|
Shiny orange peel skin symmetrical erythematous lesions seen in Grave's disease
|
|
What is necrobiosis lipoidica diabeticorum?
|
Shiny painless areas of yellow/red skin typically on skin of diabetics
associated telangiectasia |
|
What are the differential of skin disorders affecting the soles of feet?
|
Verrucas
Tinea pedis Corn and calluses Keratoderma Pitted keratolysis Palmoplantar pustulosis Juvenile plantar dermatosis |
|
What is verrucas?
|
Secondary to the human papilloma virus
Firm, hyperkeratotic lesions Pinpoint petechiae centrally within the lesions May coalesce with surrounding warts to form mosaic warts |
|
What is tinea pedis?
|
More commonly called Athlete's foot
Affected skin is moist, flaky and itchy |
|
What is corn calluses?
|
A corn is small areas of very thick skin secondary to a reactive hyperkeratosis
A callus is larger, broader and has a less well defined edge than a corn |
|
What is keratoderma?
|
May be acquired or congenital
Describes a thickening of the skin of the palms and soles Acquired causes include reactive arthritis (keratoderma blennorrhagica) |
|
What is pitted keratolysis?
|
Affects people who sweat excessively
Patients may complain of damp and excessively smelly feet Usually caused by Corynebacterium |
|
What is plamoplanta pustulosis?
|
Crops of sterile pustules affecting the palms and soles
The skin is thickened, red. Scaly and may crack More common in smokers |
|
What is Junvenile planta dermatosis?
|
Affects children. More common in atopic patients with a history of eczema
Soles become shiny and hard. Cracks may develop causing pain Worse during the summer |
|
What are the skin manifestation of SLE?
|
• photosensitive 'butterfly' rash
• discoid lupus • alopecia • livedo reticularis: net-like rash |
|
What are the skin disorder associated with DMII?
|
pyoderma gangrenosum
Necrobiosis lipoidica Candidiasis and staphlococcal infection Neuropathic ulcers Vitiligo Lipoatrophy Granuloma annulare |
|
What skin disorder is Gastric cancer associated with?
|
Acanthosis nigricans
|
|
What skin disorder is Lymphoma associated with?
|
Acquired ichthyosis
|
|
What skin disorder is Gastrointestinal and lung cancer associated with?
|
Acquired hypertrichosis lanuginosa
|
|
What skin disorder is Ovarian and lung cancer associated with?
|
Dermatomyositis
|
|
What skin disorder is Lung cancer associated with?
|
Erythema gyratum repens
|
|
What is skin disorder is Lymphoma associated with?
|
Erythroderma
|
|
What skin disorder is Pancreatic cancer associated with?
|
Migratory thrombophlebitis
|
|
What skin disorder is Glucagonoma associated with?
|
Necrolytic migratory erythema
|
|
What skin disorder is Myeloproliferative disorders associated with?
|
Pyoderma gangrenosum (bullous and non-bullous forms)
|
|
What skin disorder is Haematological malignancy e.g. Myelodysplasia - tender, purple plaques associated with?
|
Sweet's syndrome
|
|
What skin disorder is Oesophageal cancer associated with?
|
Tylosis
|
|
What is spider naevi?
|
describe a central red papule with surrounding capillaries. The lesions blanch upon pressure
- AKA:spider angiomas |
|
Where are spider naevi most found?
|
upper part of the body
|
|
How many % of people will have idopathic spide naevi?
|
Around 10-15%
|
|
What conditions are spider navi associated with?
|
• liver disease
• pregnancy • combined oral contraceptive pill |
|
What is stevens-johnson syndrome?
|
severe form of erythema multiforme associated with mucosal involvement and systemic symptoms
|
|
How does Stevens-Johnsons syndrome usually present?
|
• rash is typically maculopapular with target lesions being characteristic. May develop into vesicles or bullae
• mucosal involvement • systemic symptoms: fever, arthralgia |
|
What are the causes of stevens-johnson's syndrome?
|
• idiopathic
• bacteria: Mycoplasma, Streptococcus • viruses: herpes simplex virus, Orf • drugs: penicillin, sulphonamides, carbamazepine, allopurinol, NSAIDs, oral contraceptive pill • connective tissue disease e.g. SLE • sarcoidosis • malignancy |
|
What are strawberry naevus?
|
aka: capillary haemangioma
erythematous, raised and multilobed tumours -present in around 10% of white infants |
|
When are strawberry naevus usually develope and regress?
|
- usually not present at birth but may develop rapidly in the first month of life.
- Typically they increase in size until around 6-9 months before regressing over the next few years (around 95% resolve before 10 years of age). |
|
What is a potential complication of having strawberry naevus ?
|
• mechanical e.g. Obstructing visual fields or airway
• bleeding • ulceration • thrombocytopaenia |
|
Where are strawberry naevus usually found?
|
face, scalp and back
|
|
Which babies are most likely to have strawberry naevus?
|
Female infants, premature infants and those of mothers who have undergone chorionic villous sampling
|
|
What is cavernous haemangioma?
|
deep capillary haemangioma
|
|
If treatment is needed, what is used to treat strawberry naevi?
|
steroid
? BB |
|
What is systemic sclerosis?
|
a condition of unknown aetiology characterised by hardened, sclerotic skin and other connective tissues
|
|
What is more likely to have systemic sclerosis? and why how much?
|
women, 4x
|
|
What are the 3 patterns of disease for sysemic sclerosis?
|
Limited cutaneous systemic sclerosis
Diffuse cutaneous systemic sclerosis Scleroderma (without internal organ involvement) |
|
What is Limited cutaneous systemic sclerosis
|
• Raynaud's may be first sign
• scleroderma affects face and distal limbs predominately • associated with anti-centromere antibodies • a subtype of limited systemic sclerosis is CREST syndrome: Calcinosis, Raynaud's phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia |
|
What is
Scleroderma (without internal organ involvement)? |
• tightening and fibrosis of skin
• may be manifest as plaques (morphoea) or linear |
|
What is Diffuse cutaneous systemic sclerosis
|
• scleroderma affects trunk and proximal limbs predominately
• associated with scl-70 antibodies • hypertension, lung fibrosis and renal involvement seen • poor prognosis |
|
What antibodies are associated with systemic sclerosis?
|
• ANA positive in 90%
• RF positive in 30% • anti-scl-70 antibodies associated with diffuse cutaneous systemic sclerosis • anti-centromere antibodies associated with limited cutaneous systemic sclerosis |
|
What is tinea?
|
a term given to dermatophyte fungal infections
|
|
What are the 3 main types of tinea infection?
|
• tinea capitis - scalp
• tinea corporis - trunk, legs or arms • tinea pedis - feet |
|
What is tinea capitis?
|
- scalp ringworm
|
|
Whats causes scarring alopecia in children?
|
• a cause of scarring alopecia mainly seen in children
|
|
What happens is tinea capitis isn't treated?
|
pustular, spongy/boggy mass called a kerion may form
|
|
What is the most common dermatophytes cauing tinea capitis in US and UK?
|
Trichophyton tonsurans
|
|
What other organisim cause tinea capitis?
|
Microsporum canis acquired from cats or dogs
|
|
How is tinea capitis diagnosed?
|
lesions due to Microsporum canis green fluorescence under Wood's lamp.
most useful investigation is scalp scrapings *lesions due to Trichophyton species do not readily fluoresce under Wood's lamp |
|
How is tinea capitis treated?
|
oral antifungals:
-terbinafine for Trichophyton tonsurans infections - -griseofulvin for Microsporum infections. -Topical ketoconazole shampoo should be given for the first two weeks to reduce transmission |
|
What is tinea corporis?
|
dermatophytes infection of the skin.
|
|
What rash does tinea corporis cause?
|
• well-defined annular, erythematous lesions with pustules and papules
|
|
What organisms cause tinea corporis?
|
Trichophyton rubrum and Trichophyton verrucosum (e.g. From contact with cattle)
|
|
How is tinea corporis treated?
|
• may be treated with oral fluconazole
|
|
What is toxic epidermal necrolysis?
|
life-threatening skin disorder that is most commonly seen secondary to a drug reaction
|
|
How does the skin present with toxic epidermal necrolysis?
|
the skin develops a scalded appearance over an extensive area.
|
|
What are clinical features of toxic epidermal necrolysis?
|
• systemically unwell e.g. pyrexia, tachycardic
• positive Nikolsky's sign: the epidermis separates with mild lateral pressure |
|
What drugs are known to induce toxic epidermal necrolysis?
|
• phenytoin
• sulphonamides • allopurinol • penicillins • carbamazepine • NSAIDs |
|
What is the managment of toxic epidermal necrolysis?
|
• stop precipitating factor
• supportive care, often in intensive care unit • intravenous immunoglobulin has been shown to be effective and is now commonly used first-line • other treatment options include: immunosuppressive agents (ciclosporin and cyclophosphamide), plasmapheresis |
|
What is tuberous sclerosis?
|
- genetic condition of autosomal dominant inheritance-
-majority of features seen in TS are neuro-cutaneous |
|
What are the cutaneous features of tuberous sclerosis?
|
• depigmented 'ash-leaf' spots which fluoresce under UV light
• roughened patches of skin over lumbar spine (Shagreen patches) • adenoma sebaceum: butterfly distribution over nose • fibromata beneath nails (subungual fibromata) • caf�u-lait spots* may be seen |
|
What are the neurological features of tuberous sclerosis?
|
• developmental delay
• epilepsy (infantile spasms or partial) • intellectual impairment |
|
Other than neuro-cutaneous manifestation of tuberous sclerosis, what other manifestations can there be?
|
• retinal hamartomas: dense white areas on retina (phakomata)
• rhabdomyomas of the heart • gliomatous changes can occur in the brain lesions • polycystic kidneys, renal angiomyolipomata |
|
What is urticaria?
|
describes a local or generalised superficial swelling of the skin
|
|
What is the most common cause of urticaria?
|
Allergy more than non allergic causes
|
|
What are the clinical features of urticaria?
|
• pale, pink raised skin. Variously described as 'hives', 'wheals', 'nettle rash'
• pruritic |
|
What is the mangement of urticaria?
|
• non-sedating antihistamines are first-line
• prednisolone is used for severe or resistent episodes |
|
What conditions causes large vessel vaculitis?
|
• temporal arteritis
• Takayasu's arteritis |
|
What conditions causes medium vessel vaculitis?
|
• polyarteritis nodosa
• Kawasaki disease |
|
What conditions causes small vessel vaculitis?
|
• ANCA-associated vasculitides (Wegener's*, Churg-Strauss*, microscopic polyangiitis)
• Henoch-Schonlein purpura • cryoglobulinaemic vasculitis |
|
What is venous lake?
|
Angiomas on the lips
|
|
What is the treatment of venous lake?
|
is usually clinical and no treatment is required except for cosmetic reasons
|
|
Where is venous ulceration usually seen?
|
above the medial malleolus
|
|
What is the most important investigation in non healing ulcers?
|
• ankle-brachial pressure index (ABPI) is important in non-healing ulcers to assess for poor arterial flow which could impair healing
'normal' ABPI may be regarded as between 0.9 - 1.2. below 0.9 indicate arterial disease. Interestingly, values above 1.3 may also indicate arterial disease, in the form of false-negative results secondary to arterial calcification (e.g. In diabetics) |
|
What is the management of venous ulcers?
|
• compression bandaging, usually four layer (only treatment shown to be of real benefit)
• oral pentoxifylline, a peripheral vasodilator, improves healing rate • small evidence base supporting use of flavinoids • little evidence to suggest benefit from hydrocolloid dressings, topical growth factors, ultrasound therapy and intermittent pneumatic compression |
|
What is vitiligo?
|
an autoimmune condition which results in the loss of melanocytes and consequent depigmentation of the skin. It is thought to affect around 1% of the population and symptoms typically develop by the age of 20-30 years.
|
|
What is the clinical features of vitiligo?
|
• well demarcated patches of depigmented skin
• the peripheries tend to be most affected • trauma may precipitate new lesions (Koebner phenomenon) |
|
What conditions are vitiligo associated with?
|
• type 1 diabetes mellitus
• Addison's disease • autoimmune thyroid disorders • pernicious anaemia • alopecia areata |
|
What is the management of vitligo?
|
• sun block for affected areas of skin
• camouflage make-up • topical corticosteroids may reverse the changes if applied early • there may also be a role for topical tacrolimus and phototherapy, although caution needs to be exercised with light-skinned patients |
|
What does zinc deficiency cause?
|
• perioral dermatitis: red, crusted lesions
• acrodermatitis • alopecia • short stature • hypogonadism • hepatosplenomegaly • geophagia (ingesting clay/soil) • cognitive impairment |
|
What is psoriasis?
|
- multifactorial and not yet fully understood
- common and chronic skin disorder -• genetic: associated HLA-B13, -B17, and -Cw6. Strong concordance (70%) in identical twins • immunological: abnormal T cell activity stimulates keratinocyte proliferation. There is increasing evidence this may be mediated by a novel group of T helper cells producing IL-17, designated Th17. These cells seem to be a third T-effector cell subset in addition to Th1 and Th2 • environmental: it is recognised that psoriasis may be worsened (e.g. Skin trauma, stress), triggered (e.g. Streptococcal infection) or improved (e.g. Sunlight) by environmental factors |
|
What are the complications of having psoriasis?
|
• psoriatic arthropathy (around 10%)
• increased incidence of metabolic syndrome • increased incidence of cardiovascular disease • psychological distress |
|
How does psoriatic rash present?
|
red, scaly patches on the skin
|
|
What are recognised substypes of psoriasis?
|
• plaque psoriasis:
• flexural psoriasis: • guttate psoriasis • pustular psoriasis: |
|
What is plaque psoriasis?
|
most common sub-type resulting in the typical well demarcated red, scaly patches affecting the extensor surfaces, sacrum and scalp
|
|
What is flexural psoriasis?
|
in contrast to plaque psoriasis the skin is smooth
|
|
What is guttate psoriasis?
|
- transient multiple red, teardrop lesions appear on the body
- more common in children and adolescents - may be precipitated by a streptococcal infection 2-4 weeks prior to the lesions appearing |
|
What is pustular psoriasis?
|
commonly occurs on the palms and soles
|
|
What are the exacerbating factors of psoriasis?
|
• trauma
• alcohol • drugs: beta blockers, lithium, antimalarials (chloroquine and hydroxychloroquine), NSAIDs and ACE inhibitors • withdrawal of systemic steroids |
|
What is the management of guttate psoriasis?
|
• most cases resolve spontaneously within 2-3 months
• there is no firm evidence to support the use of antibiotics to eradicate streptococcal infection • topical agents as per psoriasis • UVB phototherapy • tonsillectomy may be necessary with recurrent episodes |
|
What is the managment of chronic plaque psoriais?
|
• regular emollients may help to reduce scale loss and reduce pruritus
• for acute control SIGN recommend: 'Short term intermittent use of a potent topical corticosteroid or a combined potent corticosteroid plus calcipotriol ointment is recommended to gain rapid improvement in plaque psoriasis.' • 'For long term topical treatment of plaque psoriasis a vitamin D analogue (e.g. Calcipotriol) is recommended.' • 'If a vitamin D analogue is ineffective or not tolerated then consider coal tar (solution, cream or lotion), tazarotene gel, or short contact dithranol (30 minute exposure in patients with a small number of relatively large plaques of psoriasis). |
|
What is the role of steroids use in psoriasis?
|
• topical steroids are commonly used in flexural psoriasis and there is also a role for mild steroids in facial psoriasis. If steroids are ineffective for these conditions vitamin D analogues or tacrolimus ointment should be used second line
• SIGN caution against the long term use of potent or very potent topical steroids due to the risk of side-effects |
|
How do you manage scalsp psoriasis?
|
• for short term control SIGN recommend either the use of potent topical corticosteroids or a combination of a potent corticosteroid and a vitamin D analogue
• 'For patients with thick scaling of the scalp, initial treatment with overnight application of salicylic acid, tar preparations, or oil preparations (eg olive oil, coconut oil) to remove thick scale is recommended. |
|
What is the role of phototherapy in managing psoriasis in secondary care ?
|
• narrow band ultraviolet B light (311-313nm) is now the treatment of choice
• photochemotherapy is also used - psoralen + ultraviolet A light (PUVA) • adverse effects: skin ageing, squamous cell cancer (not melanoma) |
|
What is the role of systemic therapy in managing psoriasis in secondary care ?
|
• methotrexate: useful if associated joint disease
• ciclosporin • systemic retinoids • biological agents: infliximab, etanercept and adalimumab • ustekinumab (IL-12 and IL-23 blocker) is showing promise in early trials |
|
What is the MOA of coal tar commonly used drugs in psoriasis?
|
probably inhibit DNA synthesis
|
|
What is the MOA of calcipotriol commonly used drugs in psoriasis?
|
vitamin D analogue which reduces epidermal proliferation and restores a normal horny layer
|
|
What is the MOA of dithranol commonly used drugs in psoriasis?
|
: inhibits DNA synthesis, wash off after 30 mins, SE: burning, staining
|
|
What are the nail changes seen in psoriasis?
|
• pitting
• onycholysis • subungual hyperkeratosis • loss of nail * Psoriatic nail changes affect both fingers and toes and do not reflect the severity of psoriasis but there is an association with psoriatic arthropathy |
|
What is amiodarone and its MOA?
|
a class III antiarrhythmic agent used in the treatment of atrial, nodal and ventricular tachycardias.
main mechanism of action is by blocking potassium channels which inhibits repolarisation and hence prolongs the action potential. Amiodarone also has other actions such as blocking sodium channels (a class I effect) |
|
What factors limits the use of amiodarone?
|
• long half-life (20-100 days)
• should ideally be given into central veins (causes thrombophlebitis) • has proarrhythmic effects due to lengthening of the QT interval • interacts with drugs commonly used concurrently e.g. Decreases metabolism of warfarin ( increase plasma level of warfarin) |
|
What are the side effects of amiodarone?
|
• thyroid dysfunction
• corneal deposits • pulmonary fibrosis/pneumonitis • liver fibrosis/hepatitis • peripheral neuropathy, myopathy • photosensitivity • 'slate-grey' appearance • thrombophlebitis and injection site reactions • bradycardia |
|
What monitoring is needed for patients started on amiodarone?
|
• TFT, LFT, U&E, CXR prior to treatment
• TFT, LFT every 6 months |
|
Angina pectoris: What 3 medications should a patient recieve in the absence of contraindication?
|
• all patients should receive aspirin and a statin in the absence of any contraindication
• sublingual glyceryl trinitrate to abort angina attacks |
|
What is the stepwise medication management of angina pectoris?
|
• NICE recommend using either a beta-blocker or a calicum channel blocker first-line based on 'comorbidities, contraindications and the person's preference'
• if a calcium channel blocker is used as monotherapy a rate-limiting one such as verapamil or diltiazem should be used. • If used in combination with a beta-blocker then use a long-acting dihydropyridine calcium-channel blocker (e.g. modified-release nifedipine). Remember that beta-blockers should not be prescribed concurrently with verapamil (risk of complete heart block) • if there is a poor response to initial treatment then medication should be increased to the maximum tolerated dose (e.g. for atenolol 100mg od) • if a patient is still symptomatic after monotherapy with a beta-blocker add a calcium channel blocker and vice versa • if a patient is on monotherapy and cannot tolerate the addition of a calcium channel blocker or a beta-blocker then consider one of the following drugs: a long-acting nitrate, ivabradine, nicorandil or ranolazine • if a patient is taking both a beta-blocker and a calcium-channel blocker then only add a third drug whilst a patient is awaiting assessment for PCI or CABG |
|
What is a common problem with nitrate medications and what can be done about it to prevent it?
|
• many patients who take nitrates develop tolerance and experience reduced efficacy
• the BNF advises that patients who develop tolerance should take the second dose of isosorbide mononitrate after 8 hours, rather than after 12 hours. This allows blood-nitrate levels to fall for 4 hours and maintains effectiveness • this effect is not seen in patients who take modified release isosorbide mononitrate |
|
What is Ivabradine?
|
• a new class of anti-anginal drug which works by reducing the heart rate
• acts on the If ('funny') ion current which is highly expressed in the sinoatrial node, reducing cardiac pacemaker activity • adverse effects: visual effects, particular luminous phenomena, are common. Bradycardia, due to the mechanism of action, may also be seen • there is no evidence currently of superiority over existing treatments of stable angina |
|
Explain angiotensin II receptor blockers. Give 3 examples.
|
- are generally used in situations where patients have not tolerated an ACE inhibitor, usually due to the development of a cough.
-Like ACE inhibitors they should be used with caution in patients with renovascular disease. Side-effects include hypotension and hyperkalaemia. - Evidence base • shown to reduce progression of renal disease in patients with diabetic nephropathy • evidence base that losartan reduces CVA and IHD mortality in hypertensive patients - Mechanism • block effects of angiotensin II at the AT1 receptor - Examples • candesartan • losartan • irbesartan - |
|
When are ACEi used?
|
- first-line treatment in younger patients with hypertension ( known to be less effective in treating hypertensive Afro-Caribbean patients)
- treat heart failure - used to treat diabetic nephropathy - secondary prevention of ischaemic heart disease |
|
What is the MOA of ACEi?
|
• inhibit the conversion angiotensin I to angiotensin II
|
|
What are the side effects of ACEi?
|
• cough: occurs in around 15% of patients and may occur up to a year after starting treatment. Thought to be due to increased bradykinin levels
• angioedema: may occur up to a year after starting treatment • hyperkalaemia • first-dose hypotension: more common in patients taking diuretics |
|
What are the cautions and contraindications for ACEi?
|
• pregnancy and breastfeeding - avoid
• renovascular disease - significant renal impairment may occur in patients who have undiagnosed bilateral renal artery stenosis • aortic stenosis - may result in hypotension • patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day) - significantly increases the risk of hypotension • hereditary of idiopathic angioedema |
|
What are the NICE suggested acceptable ranges of creatinine and eGFR changes?
|
The NICE CKD guidelines suggest that a decrease in eGFR of up to 25% or a rise in creatinine of up to 30% is acceptable
|
|
What are the monitoring thats required for ACEi patients?
|
• urea and electrolytes should be checked before treatment is initiated and after increasing the dose
• a rise in the creatinine and potassium may be expected after starting ACE inhibitors. Acceptable changes are an increase in serum creatinine, up to 30%* from baseline and an increase in potassium up to 5.5 mmol/l*. |
|
What are the clinical features of severe aortic stenosis?
|
• narrow pulse pressure
• slow rising pulse • delayed ESM • soft/absent S2 • S4 • thrill • duration of murmur • left ventricular hypertrophy or failure |
|
What are the causes of aortic stenosis?
|
• degenerative calcification (most common cause in older patients > 65 years)
• bicuspid aortic valve (most common cause in younger patients < 65 years) • William's syndrome (supravalvular aortic stenosis) • post-rheumatic disease • subvalvular: HOCM |
|
What is the management of patients with asymptomatic and symptomatic aortic stenosis?
|
• if asymptomatic then observe the patient is general rule
• if symptomatic then valve replacement • if asymptomatic but valvular gradient > 50 mmHg and with features such as left ventricular systolic dysfunction then consider surgery • balloon valvuloplasty is limited to patients with critical aortic stenosis who are not fit for valve replacement |
|
What is the CHA2DS2-VASc sore?
|
to determine the most appropriate anticoagulation strategy in AF patients
C Congestive heart failure H Hypertension (or treated hypertension) A2 Age >= 75 years D Diabetes S2 Prior Stroke or TIA V Vascular disease (including ischaemic heart disease and peripheral arterial disease) A Age 65-74 years S Sex (female) |
|
What is the anticoagulation strategy based on the CHA2DS2-VASc score?
|
Score Anticoagulation
0 No treatment is preferred to aspirin 1 Oral anticoagulants preferred to aspirin; dabigatran is an alternative 2 or more Oral anticoagulants; dabigatran is an alternative *the wording in the guidelines ('is preferred to') can be slightly confusing. It basically means that, say for a score of 0, whilst aspirin is an acceptable management option the weight of the clinical evidence would support no treatment instead |
|
What is the management of patients with <48hr history of atrial fibrillation
|
If the atrial fibrillation (AF) is definitely of less than 48 hours onset patients should be heparinised. Patients who have risk factors for ischaemic stroke should be put on lifelong oral anticoagulation. Otherwise, patients may be cardioverted using either:
• electrical - 'DC cardioversion' • pharmacology - amiodarone if structural heart disease, flecainide in those without structural heart disease Following electrical cardioversion if AF is confirmed as being less than 48 hours duration then further anticoagulation is unnecessary |
|
What is the management of patients with AF > 48 hours?
|
If the patient has been in AF for more than 48 hours then anticoagulation should be given for at least 3 weeks prior to cardioversion. An alternative strategy is to perform a transoesophageal echo (TOE) to exclude a left atrial appendage (LAA) thrombus. If excluded patients may be heparinised and cardioverted immediately.
If there is a high risk of cardioversion failure (e.g. Previous failure or AF recurrence) then it is recommend to have at least 4 weeks amiodarone or sotalol prior to electrical cardioversion Following electrical cardioversion patients should be anticoagulated for at least 4 weeks. After this time decisions about anticoagulation should be taken on an individual basis depending on the risk of recurrence |
|
What is the management guideline on the management of patients with AF who developed a stroke or TIA?
|
• following a stroke or TIA warfarin should be given as the anticoagulant of choice. Aspirin/dipyridamole should only be given if needed for the treatment of other comorbidities
in acute stroke patients, in the absence of haemorrhage, anticoagulation therapy should be commenced after 2 weeks. If imaging shows a very large cerebral infarction then the initiation of anticoagulation should be delayed |
|
What are the agents used to control rate in patients with AF?
|
• beta-blockers
• calcium channel blockers • digoxin (not considered first-line anymore as they are less effective at controlling the heart rate during exercise. However, they are the preferred choice if the patient has coexistent heart failure) |
|
What are the agents used to maintain sinus rhytm in patients with history of AF?
|
• sotalol
• amiodarone • flecainide • others (less commonly used in UK): disopyramide, dofetilide, procainamide, propafenone, quinidine |
|
Which group of AF patients favour rate control?
|
Older than 65 years
History of ischaemic heart disease |
|
What group of AF patients favour rhythm control?
|
Younger than 65 years
Symptomatic First presentation Lone AF or AF secondary to a corrected precipitant (e.g. Alcohol) Congestive heart failure |
|
What is atrial flutter?
|
Atrial flutter is a form of supraventricular tachycardia characterised by a succession of rapid atrial depolarisation waves.
|
|
What are the ECG findings of atrial flutter?
|
• 'sawtooth' appearance
• as the underlying atrial rate is often around 300/min the ventricular or heart rate is dependent on the degree of AV block. For example if there is 2:1 block the ventricular rate will be 150/min • flutter waves may be visible following carotid sinus massage or adenosine |
|
What is the management of atrial flutter?
|
• is similar to that of atrial fibrillation although mediction may be less effective
• atrial flutter is more sensitive to cardioversion however so lower energy levels may be used • radiofrequency ablation of the tricuspid valve isthmus is curative for most patients |
|
What is B-type natriuretic peptide ?
|
B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to strain.
|
|
What factors increase level of BNP?
|
- heart failure
- any cause of left ventricular dysfunction such as myocardial ischaemia or valvular disease may raise levels. - reduced excretion in patients with chronic kidney disease |
|
What factors decrease level of BNP?
|
ACE inhibitors, angiotensin-2 receptor blockers and diuretics.
|
|
What are the clinical uses of BNP?
|
Diagnosing patients with acute dyspnoea
• a low concentration of BNP(< 100pg/ml) makes a diagnosis of heart failure unlikely, but raised levels should prompt further investigation to confirm the diagnosis • NICE currently recommends BNP as a helpful test to rule out a diagnosis of heart failure Prognosis in patients with chronic heart failure • initial evidence suggests BNP is an extremely useful marker of prognosis Guiding treatment in patients with chronic heart failure • effective treatment lowers BNP levels |
|
Where are beta blockers used?
|
• angina
• post-myocardial infarction • heart failure: beta-blockers were previously avoided in heart failure but there is now strong evidence that certain beta-blockers improve both symptoms and mortality • arrhythmias: beta-blockers have now replaced digoxin as the rate-control drug of choice in atrial fibrillation • hypertension: the role of beta-blockers has diminished in recent years due to a lack of evidence in terms of reducing stroke and myocardial infarction. • thyrotoxicosis • migraine prophylaxis • anxiety |
|
What are the examples of beta blocker?
|
• atenolol
• propranolol: one of the first beta-blockers to be developed. Lipid soluble therefore crosses the blood-brain barrier |
|
What are the side effects of beta blocker?
|
• bronchospasm
• cold peripheries • fatigue • sleep disturbances, including nightmares |
|
What are the contraindication of beta blocker use?
|
• uncontrolled heart failure
• asthma • sick sinus syndrome • concurrent verapamil use: may precipitate severe bradycardia |
|
Explain its indication, notes and side effects of CCB: verpamil.
|
Angina, hypertension, arrhythmias
Highly negatively inotropic Should not be given with beta-blockers as may cause heart block S/E: Heart failure, constipation, hypotension, bradycardia, flushing |
|
Explain its indication, notes and side effects of CCB: Diltiazem
|
Angina, hypertension
Less negatively inotropic than verapamil but caution should still be exercised when patients have heart failure or are taking beta-blockers S/E:Hypotension, bradycardia, heart failure, ankle swelling |
|
Explain its indication, notes and side effects of CCB: Nifedipine, amlodipine, felodipine
(dihydropyridines) |
Hypertension, angina, Raynaud's
Affects the peripheral vascular smooth muscle more than the myocardium and therefore do not result in worsening of heart failure S/E: Flushing, headache, ankle swelling |
|
Characteristic exam features of: Myocardial infarction
|
Cardiac-sounding pain
• heavy, central chest pain they may radiate to the neck and left arm • nausea, sweating • elderly patients and diabetics may experience no pain Risk factors for cardiovascular disease |
|
Characteristic exam features of: Pneumothorax
|
History of asthma, Marfan's etc
Sudden dyspnoea and pleuritic chest pain |
|
Characteristic exam features of: Pulmonary embolism
|
Sudden dyspnoea and pleuritic chest pain
Calf pain/swelling Current combined pill user, malignancy |
|
Characteristic exam features of: Pericarditis
|
Sharp pain relieved by sitting forwards
May be pleuritic in nature |
|
Characteristic exam features of: Dissecting aortic aneurysm
|
'Tearing' chest pain radiating through to the back
Unequal upper limb blood pressure |
|
Characteristic exam features of: Gastro-oesophageal reflux disease
|
Burning retrosternal pain
Other possible symptoms include regurgitation and dysphagia |
|
Characteristic exam features of: Musculoskeletal chest pain
|
One of the most common diagnoses made in the Emergency Department. The pain is often worse on movement or palpation.
Pain often precedes the rash May be precipitated by trauma or coughing Shingles |
|
what is the management of patients presenting with acute chest pain?
|
Immediate management of suspected acute coronary syndrome (ACS)
• glyceryl trinitrate • aspirin 300mg. NICE do not recommend giving other antiplatelet agents (i.e. Clopidogrel) outside of hospital • do not routinely give oxygen, only give if sats < 94%* • perform an ECG as soon as possible but do not delay transfer to hospital. A normal ECG does not exclude ACS Referral • current chest pain or chest pain in the last 12 hours with an abnormal ECG: emergency admission • chest pain 12-72 hours ago: refer to hospital the same-day for assessment • chest pain > 72 hours ago: perform full assessment with ECG and troponin measurement before deciding upon further action *NICE suggest the following in terms of oxygen therapy: • do not routinely administer oxygen, but monitor oxygen saturation using pulse oximetry as soon as possible, ideally before hospital admission. Only offer supplemental oxygen to: • people with oxygen saturation (SpO2) of less than 94% who are not at risk of hypercapnic respiratory failure, aiming for SpO2 of 94-98% • people with chronic obstructive pulmonary disease who are at risk of hypercapnic respiratory failure, to achieve a target SpO2 of 88-92% until blood gas analysis is available. |
|
What is NICE's definition of anginal pain?
|
NICE define anginal pain as the following:
• 1. constricting discomfort in the front of the chest, neck, shoulders, jaw or arms • 2. precipitated by physical exertion • 3. relieved by rest or GTN in about 5 minutes • patients with all 3 features have typical angina • patients with 2 of the above features have atypical angina • patients with 1 or none of the above features have non-anginal chest pain If patients have typical anginal symptoms and a risk of CAD is greater than 90% then no further diagnostic testing is required. It should be noted that all men over the age of 70 years who have typical anginal symptoms fall into this category. For patients with an estimated risk of 10-90% the following investigations are recommended. Note the absence of the exercise tolerance test: |
|
what is the diagnostic testing for paitents with anginal patient and an estimated likelihood of CAD of 61-90%?
|
Coronary angiography
|
|
what is the diagnostic testing for paitents with anginal patient and an estimated likelihood of CAD of 30-60%?
|
Functional imaging, for example:
• myocardial perfusion scan with SPECT • stress echocardiography • first-pass contrast-enhanced magnetic resonance (MR) perfusion • MR imaging for stress-induced wall motion abnormalities. |
|
what is the diagnostic testing for paitents with anginal patient and an estimated likelihood of CAD of 61-90%?
|
CT calcium scoring
|
|
What are the clinical features of complete heart block?
|
• syncope
• heart failure • regular bradycardia (30-50 bpm) • wide pulse pressure • JVP: cannon waves in neck • variable intensity of S1 |
|
What are the 3 different types of heart block?
|
First degree heart block
• PR interval > 0.2 seconds Second degree heart block • type 1 (Mobitz I, Wenckebach): progressive prolongation of the PR interval until a dropped beat occurs • type 2 (Mobitz II): PR interval is constant but the P wave is often not followed by a QRS complex Third degree (complete) heart block • there is no association between the P waves and QRS complexes |
|
When is digoxin mainly used?
|
Digoxin is a cardiac glycoside now mainly used for rate control in the management of atrial fibrillation. As it has positive inotropic properties it is sometimes used for improving symptoms (but not mortality) in patients with heart failure.
|
|
What is the MOA of digoxin?
|
• decreases conduction through the atrioventricular node which slows the ventricular rate in atrial fibrillation and flutter
• increases the force of cardiac muscle contraction due to inhibition of the Na+/K+ ATPase pump. Also stimulates vagus nerve |
|
What are the clinical features of digoxin toxicity?
|
• generally unwell, lethargy, nausea & vomiting, anorexia, confusion, yellow-green vision
• arrhythmias (e.g. AV block, bradycardia) |
|
What are the precipitating factors of digoxin toxicity?
|
• classically: hypokalaemia*
• increasing age • renal failure • myocardial ischaemia • hypomagnesaemia, hypercalcaemia, hypernatraemia, acidosis • hypoalbuminaemia • hypothermia • hypothyroidism • drugs: amiodarone, quinidine, verapamil, diltiazem, spironolactone (compete for secretion in distal convoluted tubule therefore reduce excretion), ciclosporin. Also drugs which cause hypokalaemia e.g. thiazides and loop diuretics *hyperkalaemia may also worsen digoxin toxicity, although this is very small print |
|
What is the managment of digoxin toxicity?
|
• Digibind
• correct arrhythmias • monitor potassium |
|
Coronary artery and its ECG changes: anteroseptal
|
LAD, V1-V4
|
|
Coronary artery and its ECG changes:inferior
|
RCA, II/ III/ aVF
|
|
Coronary artery and its ECG changes:Anterolateral
|
Left anterior descending or left circumflex, V4-6, I, aVL
|
|
Coronary artery and its ECG changes:Lateral
|
Left circumflex, I, aVL +/- V5-6
|
|
Coronary artery and its ECG changes: Posterior
|
Usually left circumflex, also right coronary, Tall R waves V1-2
|
|
What are the causes of LBBB?
|
• ischaemic heart disease
• hypertension • aortic stenosis • cardiomyopathy • idiopathic fibrosis |
|
ECG and coronary arteries
|
Anteroseptal: V1-V4, Left anterior descending
Inferior: II, III, aVF, Right coronary Anterolateral: V4-6, I, aVL, Left anterior descending or left circumflex Lateral:I, aVL +/- V5-6, Left circumflex Posterior:Tall R waves V1-2,Usually left circumflex, also right coronary |
|
What are the causes of RBBB?
|
• normal variant - more common with increasing age
• chronically increased right ventricular pressure - e.g. cor pulmonale • pulmonary embolism • myocardial infarction • cardiomyopathy or myocarditis |
|
What are the normal ECG variants in an athlete?
|
• sinus bradycardia
• junctional rhythm • first degree heart block • Wenckebach phenomenon |
|
What are the ECG changes in acute MI?
|
• hyperacute T waves are often the first sign of MI but often only persists for a few minutes
• ST elevation may then develop • the T waves typically become inverted within the first 24 hours. The inversion of the T waves can last for days to months • pathological Q waves develop after several hours to days. This change usually persists indefinitely Definition of ST elevation* • new ST elevation at the J-point in two contiguous leads with the cut-off points: >=0.2 mV in men or >= 0.15 mV in women in leads V2-V3 and/or >= 0.1 mV in other leads |
|
What is hypertrophic obstructive cardiomyopathy ?
|
an autosomal dominant disorder of muscle tissue caused by defects in the genes encoding contractile proteins. The estimated prevalence is 1 in 500.
|
|
What are the clinical features of hypertrophic obstructive cardiomyopathy?
|
• often asymptomatic
• dyspnoea, angina, syncope • sudden death (most commonly due to ventricular arrhythmias), arrhythmias, heart failure • jerky pulse, large 'a' waves, double apex beat • ejection systolic murmur: increases with Valsalva manoeuvre and decreases on squatting |
|
What conditions are associated with hypertrophic obstructive cardiomyopathy?
|
• Friedreich's ataxia
• Wolff-Parkinson White |
|
What are the clinical features seen on Echo for patients with hypertrophic obstructive cardiomyopathy?
|
• mitral regurgitation (MR)
• systolic anterior motion (SAM) of the anterior mitral valve leaflet • asymmetric hypertrophy (ASH) |
|
What are the clinical features of ECG changes for patients with hypertrophic obstructive cardiomyopathy?
|
• left ventricular hypertrophy
• progressive T wave inversion • deep Q waves • atrial fibrillation may occasionally be seen |
|
What determines the choice of investigation for suspected heart failure patients?
|
Previous myocardial infarction
• arrange echocardiogram within 2 weeks No previous myocardial infarction • measure serum natriuretic peptides (BNP) • if levels are 'high' arrange echocardiogram within 2 weeks • if levels are 'raised' arrange echocardiogram within 6 weeks |
|
What is B-type natriuretic peptide?
|
a hormone produced mainly by the left ventricular myocardium in response to strain. Very high levels are associated with a poor prognosis
|
|
What is the the classication for BNP level?
|
BNP
High levels > 400 pg/ml (116 pmol/litre) Raised levels 100-400 pg/ml (29-116 pmol/litre) Normal levels < 100 pg/ml (29 pmol/litre) |
|
What increases BNP levels?
|
Left ventricular hypertrophy
Ischaemia Tachycardia Right ventricular overload Hypoxaemia (including pulmonary embolism) GFR < 60 ml/min Sepsis COPD Diabetes Age > 70 Liver cirrhosis |
|
What decreases BNP level?
|
Obesity
Diuretics ACE inhibitors Beta-blockers Angiotensin 2 receptor blockers Aldosterone antagonists |
|
What are the key changes of NICE hypertension 2011 guidelines?
|
• classifying hypertension into stages
• recommending the use of ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) • calcium channel blockers are now considered superior to thiazides • bendroflumethiazide is no longer the thiazide of choice |
|
What is the criteria for stage 1 hypertension?
|
Clinic BP >= 140/90 mmHg and subsequent ABPM daytime average or HBPM average BP >= 135/85 mmHg
|
|
What is the criteria for stage 2 hypertension?
|
Clinic BP >= 160/100 mmHg and subsequent ABPM daytime average or HBPM average BP >= 150/95 mmHg
|
|
What is the criteria for severe hypertension?
|
Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 110 mmHg
|
|
How is hypertension diagnosed?
|
If a BP reading is >= 140 / 90 mmHg patients should be offered ABPM to confirm the diagnosis.
Patients with a BP reading of >= 180/110 mmHg should be considered for immediate treatment. Ambulatory blood pressure monitoring (ABPM) • at least 2 measurements per hour during the person's usual waking hours (for example, between 08:00 and 22:00) • use the average value of at least 14 measurements If ABPM is not tolerated or declined HBPM should be offered. Home blood pressure monitoring (HBPM) • for each BP recording, two consecutive measurements need to be taken, at least 1 minute apart and with the person seated • BP should be recorded twice daily, ideally in the morning and evening • BP should be recorded for at least 4 days, ideally for 7 days • discard the measurements taken on the first day and use the average value of all the remaining measurements |
|
What is the management plan for hypertensive patients?
|
ABPM/HBPM >= 135/85 mmHg (i.e. stage 1 hypertension)
• treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 20% or greater ABPM/HBPM >= 150/95 mmHg (i.e. stage 2 hypertension) • offer drug treatment regardless of age For patients < 40 years consider specialist referral to exclude secondary causes. Step 1 treatment • patients < 55-years-old: ACE inhibitor (A) • patients > 55-years-old or of Afro-Caribbean origin: calcium channel blocker Step 2 treatment • ACE inhibitor + calcium channel blocker (A + C) Step 3 treatment • add a thiazide diuretic (D, i.e. A + C + D) • NICE now advocate using either chlorthalidone (12.5-25.0 mg once daily) or indapamide (1.5 mg modified-release once daily or 2.5 mg once daily) in preference to a conventional thiazide diuretic such as bendroflumethiazide NICE define a clinic BP >= 140/90 mmHg after step 3 treatment with optimal or best tolerated doses as resistant hypertension. They suggest step 4 treatment or seeking expert advice Step 4 treatment • consider further diuretic treatment • if potassium < 4.5 mmol/l add spironolactone 25mg od • if potassium > 4.5 mmol/l add higher-dose thiazide-like diuretic treatment • if further diuretic therapy is not tolerated, or is contraindicated or ineffective, consider an alpha- or beta-blocker If BP still not controlled seek specialist advice. |
|
What is the blood pressure managment target for patient < 80y and > 80y?
|
Clinic BP ABPM / HBPM
Age < 80 years 140/90 mmHg 135/85 mmHg Age > 80 years 150/90 mmHg 145/85 mmHg |
|
What is direct renin inhibitor ( eg. aliskiren- named rasilez)
|
• by inhibiting renin blocks the conversion of angiotensinogen to angiotensin I
• no trials have looked at mortality data yet. Trials have only investigated fall in blood pressure. Initial trials suggest aliskiren reduces blood pressure to a similar extent as angiotensin converting enzyme (ACE) inhibitors or angiotensin-II receptor antagonists • adverse effects were uncommon in trials although diarrhoea was occasionally seen • only current role would seem to be in patients who are intolerant of more established antihypertensive drugs |
|
What are the causes of secodnary hypertension?
|
Renal - accounts for 80% of secondary hypertension
• glomerulonephritis • pyelonephritis • adult polycystic kidney disease • renal artery stenosis Endocrine disorders • Cushing's syndrome • primary hyperaldosteronism including Conn's syndrome • Liddle's syndrome • congenital adrenal hyperplasia (11-beta hydroxylase deficiency) • phaeochromocytoma • acromegaly Others • pregnancy • coarctation of the aorta • the combined oral contraceptive pill • steroids • MAOI |
|
Infective endocarditis: prophylaxis
|
NICE recommends the following procedures do not require prophylaxis:
• dental procedures • upper and lower gastrointestinal tract procedures • genitourinary tract; this includes urological, gynaecological and obstetric procedures and childbirth • upper and lower respiratory tract; this includes ear, nose and throat procedures and bronchoscopy The guidelines do however suggest: • any episodes of infection in people at risk of infective endocarditis should be investigated and treated promptly to reduce the risk of endocarditis developing • if a person at risk of infective endocarditis is receiving antimicrobial therapy because they are undergoing a gastrointestinal or genitourinary procedure at a site where there is a suspected infection they should be given an antibiotic that covers organisms that cause infective endocarditis |
|
Isolated systolic hypertension
|
Isolated systolic hypertension (ISH) is common in the elderly, affecting around 50% of people older than 70 years old. The Systolic Hypertension in the Elderly Program (SHEP) back in 1991 established that treating ISH reduced both strokes and ischaemic heart disease. Drugs such as thiazides were recommended as first line agents. This approach is contradicated by the 2011 NICE guidelines which recommends treating ISH in the same stepwise fashion as standard hypertension.
|
|
What is long QT syndrome?
|
Long QT syndrome (LQTS) is an inherited condition associated with delayed repolarization of the ventricles. It is important to recognise as it may lead to ventricular tachycardia and can therefore cause collapse/sudden death. The most common variants of LQTS (LQT1 & LQT2) are caused by defects in the alpha subunit of the slow delayed rectifier potassium channel. A normal corrected QT interval is less than 430 ms in males and 450 ms in females.
|
|
What causes prolonged QT syndrome?
|
1) Congenital
• Jervell-Lange-Nielsen syndrome (includes deafness and is due to an abnormal potassium channel) • Romano-Ward syndrome (no deafness) 2) Drugs* • amiodarone, sotalol, class 1a antiarrhythmic drugs • tricyclic antidepressants, selective serotonin reuptake inhibitors (especially citalopram) • methadone • chloroquine • terfenadine** • erythromycin • haloperidol **a non-sedating antihistamine and classic cause of prolonged QT in a patient, especially if also taking P450 enzyme inhibitor, e.g. Patient with a cold takes terfenadine and erythromycin at the same time 3) Other • electrolyte: hypocalcaemia, hypokalaemia, hypomagnesaemia • acute myocardial infarction • myocarditis • hypothermia • subarachnoid haemorrhage |
|
what are the clinical features of long QT syndrome?
|
• may be picked up on routine ECG or following family screening
• Long QT1 - usually associated with exertional syncope, often swimming • Long QT2 - often associated with syncope occurring following emotional stress, exercise or auditory stimuli • Long QT3 - events often occur at night or at rest • sudden cardiac death |
|
What is the management of long QT syndrome?
|
• avoid drugs which prolong the QT interval and other precipitants if appropriate (e.g. Strenuous exercise)
• beta-blockers*** • implantable cardioverter defibrillators in high risk cases ***note sotalol may exacerbate long QT syndrome |
|
What is the NICE guideline for the management of patients following a MI?
|
All patients should be offered the following drugs:
• ACE inhibitor • beta-blocker • aspirin • statin Clopidogrel • ST-segment-elevation MI: patients treated with a combination of aspirin and clopidogrel during the first 24 hours after the MI should continue this treatment for at least 4 weeks • non-ST segment elevation myocardial infarction (NSTEMI): following the 2010 NICE unstable angina and NSTEMI guidelines clopidogrel should be given for the first 12 months if the 6 month mortality risk* is > 1.5% Aldosterone antagonists • patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction, treatment with an aldosterone antagonist licensed for post-MI treatment (e.g. eplerenone) should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy *this can be calculated using scoring systems such as GRACE |
|
What are nitrates and its side effects?
|
Nitrates are a group of drugs which have vasodilating effects. The main indications for their use is in the management of angina and the acute treatment of heart failure. Sublingual glyceryl trinitrate is the most common drug used in patients with ischaemic heart disease to relieve angina attacks.
Mechanism of action • cause release of nitric oxide in smooth muscle, increasing cGMP which leads to a fall in intracellular calcium levels • in angina they both dilate the coronary arteries and also reduce venous return which in turn reduces left ventricular work, reducing myocardial oxygen demand Side-effects • hypotension • tachycardia • headaches |
|
What are the indications for permanent pacemaker insertion?
|
• persistent symptomatic bradycardia e.g. sick sinus syndome
• complete heart block • Mobitz type II AV block • persistent AV block after myocardial infarction |
|
Define pre-eclampsia.
|
Pre-eclampsia is a condition seen after 20 weeks gestation characterised by pregnancy-induced hypertension in association with proteinuria (> 0.3g / 24 hours). Oedema used to be third element of the classic triad but is now often not included in the definition as it is not specific
|
|
What are the associated complications of pre-eclampsia?
|
• fetal: prematurity, intrauterine growth retardation
• eclampsia • haemorrhage: placental abruption, intra-abdominal, intra-cerebral • cardiac failure • multi-organ failure |
|
What are the risk factors of pre-eclampsia?
|
• > 40 years old
• nulliparity (or new partner) • multiple pregnancy • body mass index > 30 kg/m^2 • diabetes mellitus • pregnancy interval of more than 10 years • family history of pre-eclampsia • previous history of pre-eclampsia • pre-existing vascular disease such as hypertension or renal disease |
|
What are the clinical features of severe pre-eclampsia?
|
• hypertension: typically > 170/110 mmHg and proteinuria as above
• proteinuria: dipstick ++/+++ • headache • visual disturbance • papilloedema • RUQ/epigastric pain • hyperreflexia • platelet count < 100 * 106/l, abnormal liver enzymes or HELLP syndrome |
|
What is the management of patients with pre-eclampsia?
|
• consensus guidelines recommend treating blood pressure > 160/110 mmHg although many clinicians have a lower threshold
• oral labetalol is now first-line following the 2010 NICE guidelines. Nifedipine and hydralazine may also be used • delivery of the baby is the most important and definitive management step. The timing depends on the individual clinical scenario |
|
Which medications may exacerbate heart failure?
|
• thiazolidinediones*: pioglitazone is contraindicated as it causes fluid retention
• verapamil: negative inotropic effect • NSAIDs**/glucocorticoids: should be used with caution as they cause fluid retention • class I antiarrhythmics; flecainide (negative inotropic and proarrhythmic effect) *pioglitazone is now the only thiazolidinedione on the market **low-dose aspirin is an exception - many patients will have coexistent cardiovascular disease and the benefits of taking aspirin easily outweigh the risks |
|
Define biological ( bioproesthetic) valves.
|
Usually bovine or porcine in origin
Major disadvantage is structural deterioration and calcification over time. Most older patients ( > 65 years for aortic valves and > 70 years for mitral valves) receive a bioprosthetic valve Long-term anticoagulation not usually needed. Warfarin may be given for the first 3 months depending on patient factors. Low-dose aspirin is given long-term. |
|
Define mechanical valves.
|
The most common type now implanted is the bileaflet valve. Ball-and-cage valves are rarely used nowadays
Mechanical valves have a low failure rate Major disadvantage is the increased risk of thrombosis meaning long-term anticoagulation is needed. Aspirin is normally given in addition unless there is a contraindication. Target INR • aortic: 2.0-3.0 • mitral: 2.5-3.5 |
|
What is the therapetic drug monitoring for lithum?
|
• range = 0.4 - 1.0 mmol/l
• take 12 hrs post-dose |
|
What is the therapetic drug monitoring for ciclopsorin?
|
• trough levels immediately before dose
|
|
What is the therapetic drug monitoring for digoxin?
|
• at least 6 hrs post-dose
|
|
What is the therapetic drug monitoring for phenytoin?
|
trough levels immediately before dose
|
|
Define syncope.
|
Syncope may be defined as a transient loss of consciousness due to global cerebral hypoperfusion with rapid onset, short duration and spontaneous complete recovery.
|
|
What are the investigations/examination for evaluating causes of syncope?
|
• cardiovascular examination
• postural blood pressure readings: a symptomatic fall in systolic BP > 20 mmHg or diastolic BP > 10 mmHg or decrease in systolic BP < 90 mmHg is considered diagnostic • ECG • carotid sinus massage • tilt table test • 24 hour ECG |
|
What conditions cause syncope and how are they caterogized?
|
Reflex syncope (neurally mediated)
• vasovagal: triggered by emotion, pain or stress. Often referred to as 'fainting' • situational: cough, micturition, gastrointestinal • carotid sinus syncope Orthostatic syncope • primary autonomic failure: Parkinson's disease, Lewy body dementia • secondary autonomic failure: e.g. Diabetic neuropathy, amyloidosis, uraemia • drug-induced: diuretics, alcohol, vasodilators • volume depletion: haemorrhage, diarrhoea Cardiac syncope • arrhythmias: bradycardias (sinus node dysfunction, AV conduction disorders) or tachycardias (supraventricular, ventricular) • structural: valvular, myocardial infarction, hypertrophic obstructive cardiomyopathy • others: pulmonary embolism Reflex syncope is the most common cause in all age groups although orthostatic and cardiac causes become progressively more common in older patients. |
|
signs of life threatening asthma
|
� PEFR < 33% best or predicted
� Oxygen sats < 92% � Silent chest, cyanosis or feeble respiratory effort � Bradycardia, dysrhythmia or hypotension � Exhaustion, confusion or coma |
|
signs of severe asthma
|
� PEFR 33 - 50% best or predicted
� Can't complete sentences � RR > 25/min � Pulse > 110 bpm |
|
Signs of moderate asthma
|
� PEFR > 50% best or predicted
� Speech normal � RR < 25 / min � Pulse < 110 bpm |
|
Management of moderate asthma
|
• beta 2 agonists such as salbutamol, either nebulised or via a spacer (4-6 puffs, given one at a time and inhaled separately, repeated at intervals of 10-20 minutes)
• if PEFR between 50-75% then prednisolone 40-50mg |
|
Management of severe asthma
|
• consider admission
• oxygen to hypoxaemic patients to maintain a SpO2 of 94-98% • beta 2 agonists such as salbutamol, either nebulised or via a spacer (4-6 puffs, given one at a time and inhaled separately, repeated at intervals of 10-20 minutes) • prednisolone 40-50mg • if no response then admit |
|
Management of life threatening asthma
|
• arrange immediate admission (999 call)
• oxygen to hypoxaemic patients to maintain a SpO2 of 94-98% • nebulised beta 2 agonists (e.g. Salbutamol) + ipratropium • prednisolone 40-50mg or IV hydrocortisone 100mg |
|
signs of increase possibility of asthma during examination and history
|
� Wheeze, breathlessness, chest tightness and cough, worse at night/early morning
� History of atopic disorder � Wheeze heard on auscultation � Unexplained peripheral blood eosinophilia |
|
signs of decreased possibility of asthma during examination and history
|
� Prominent dizziness, light-headedness, peripheral tingling
� Chronic productive cough in the absence of wheeze or breathlessness � Repeatedly normal physical examination � Significant smoking history (i.e. > 20 pack-years) � Normal PEF or spirometry when symptomatic |
|
If FEV1/FVC < 0.7 ( asthma), what is the treatment management?
If FEV1/FVC > 0.7 ( asthma), what is the treatment management? |
• FEV1/FVC < 0.7: trial of treatment
• FEV1/FVC > 0.7: further investigation/consider referral |
|
What value of improvement in FEV1 is considered significant?
|
A > 400 ml improvement in FEV1 is considered significant
• before and after 400 mcg inhaled salbutamol in patients with diagnostic uncertainty and airflow obstruction present at the time of assessment • if there is an incomplete response to inhaled salbutamol, after either inhaled corticosteroids (200 mcg twice daily beclometasone equivalent for 6-8 weeks) or oral prednisolone (30 mg once daily for 14 days) |
|
What value of peak flow is considered significant?
|
It is now advised to interpret peak flow variability with caution due to the poor sensitivity of the test
• diurnal variation % = [(Highest - Lowest PEFR) / Highest PEFR] x 100 • assessment should be made over 2 weeks greater than 20% diurnal variation is considered significant |
|
What are the common causes of occupational asthma?
|
• isocyanates - the most common cause. Example occupations include spray painting and foam moulding using adhesives
• platinum salts • soldering flux resin • glutaraldehyde • flour • epoxy resins • proteolytic enzymes |
|
How is occupational asthma diagnosed?
|
• specific recommendations are made in the 2007 joint British Thoracic Society and SIGN guidelines
serial measurements of peak expiratory flow are recommended at work and away from work |
|
What is the step 1 of asthma?
|
Inhaled short-acting B2 agonist as required
|
|
What is the step 2 of asthma management?
|
Add inhaled steroid at 200-800 mcg/day*
400 mcg is an appropriate starting dose for many patients. Start at dose of inhaled steroid appropriate to severity of disease *beclometasone dipropionate or equivalent |
|
What is step 3 of asthma management?
|
1. Add inhaled long-acting B2 agonist (LABA)
2. Assess control of asthma: • good response to LABA - continue LABA • benefit from LABA but control still inadequate: continue LABA and increase inhaled steroid dose to 800 mcg/day* (if not already on this dose) • no response to LABA: stop LABA and increase inhaled steroid to 800 mcg/ day.* If control still inadequate, institute trial of other therapies, leukotriene receptor antagonist or SR theophylline *beclometasone dipropionate or equivalent |
|
What is step 4 of asthma management?
|
Consider trials of:
• increasing inhaled steroid up to 2000 mcg/day* • addition of a fourth drug e.g. Leukotriene receptor antagonist, SR theophylline, B2 agonist tablet *beclometasone dipropionate or equivalent |
|
What is step 5 of asthma management?
|
Use daily steroid tablet in lowest dose providing adequate control. Consider other treatments to minimise the use of steroid tablets
Maintain high dose inhaled steroid at 2000 mcg/day* Refer patient for specialist care *beclometasone dipropionate or equivalent |
|
What are leukotriene receptor antagonists? Medication example.
|
• e.g. Montelukast, zafirlukast
• have both anti-inflammatory and bronchodilatory properties • should be used when patients are poorly controlled on high-dose inhaled corticosteroids and a long-acting b2-agonist • particularly useful in aspirin-induced asthma • associated with the development of Churg-Strauss syndrome |
|
What medication is more lipophillic than beclometasone?
|
fluticasone
|
|
What is long acting B2 agonists better than doubling inhaled steroid?
|
Long acting B2-agonists acts as bronchodilators but also inhibit mediator release from mast cells. Recent meta-analysis showed adding salmeterol improved symptoms compared to doubling the inhaled steroid dose
|
|
What is bronchiectasis?
|
Bronchiectasis describes a permanent dilatation of the airways secondary to chronic infection or inflammation
|
|
What is the management of bronchiectasis?
|
. After assessing for treatable causes (e.g. immune deficiency) management is as follows:
• physical training (e.g. inspiratory muscle training) - has a good evidence base for patients with non-cystic fibrosis bronchiectasis • postural drainage • antibiotics for exacerbations + long-term rotating antibiotics in severe cases • bronchodilators in selected cases • immunisations • surgery in selected cases (e.g. Localised disease) |
|
What organisms are most commonly isolated from patients with bronchiectasis?
|
Most common organisms isolated from patients with bronchiectasis:
• Haemophilus influenzae (most common) • Pseudomonas aeruginosa • Klebsiella spp. • Streptococcus pneumoniae |
|
Who should be considered for diagnosis of COPD?
|
NICE recommend considering a diagnosis of COPD in patients over 35 years of age who are smokers or ex-smokers and have symptoms such as exertional breathlessness, chronic cough or regular sputum production.
|
|
What investigations are recommended in patients with suspected COPD?
|
• post-bronchodilator spirometry to demonstrate airflow obstruction: FEV1/FVC ratio less than 70%
• chest x-ray: hyperinflation, bullae, flat hemidiaphragm. Also important to exclude lung cancer • full blood count: exclude secondary polycythaemia • body mass index (BMI) calculation |
|
Categorise severity of COPD using FEV1
|
Post-bronchodilator FEV1/FVC, FEV1 (of predicted), Severity
< 0.7 > 80% Stage 1 - Mild** < 0.7 50-79% Stage 2 - Moderate < 0.7 30-49% Stage 3 - Severe < 0.7 < 30% Stage 4 - Very severe *note that the grading system has changed following the 2010 NICE guidelines. If the FEV1 is greater than 80% predicted but the post-bronchodilator FEV1/FVC is < 0.7 then this is classified as Stage 1 - mild **symptoms should be present to diagnose COPD in these patients |
|
Why is measuring peak expiratory flow limted value in COPD patients?
|
it may underestimate the degree of airflow obstruction
|
|
How many hours per day should COPD patient on LTOT use it for?
|
15 hours
|
|
What is used to supply oxygen for LTOT?
|
Oxygen concentrators are used to provide a fixed supply for LTOT.
|
|
in which group of patients should LTOT be assessed for?
|
• very severe airflow obstruction (FEV1 < 30% predicted). Assessment should be 'considered' for patients with severe airflow obstruction (FEV1 30-49% predicted)
• cyanosis • polycythaemia • peripheral oedema • raised jugular venous pressure • oxygen saturations less than or equal to 92% on room air |
|
How is a patient who is considered for LTOT assessed? and when is LTOT offered?
|
Assessment is done by measuring arterial blood gases on 2 occasions at least 3 weeks apart in patients with stable COPD on optimal management.
Offer LTOT to patients with a pO2 of < 7.3 kPa or to those with a pO2 of 7.3 - 8 kPa and one of the following: • secondary polycythaemia • nocturnal hypoxaemia • peripheral oedema • pulmonary hypertension |
|
What organisms most commonly cause infective exacerbation of COPD?
|
The most common bacterial organisms that cause infective exacerbations of COPD are:
• Haemophilus influenzae (most common cause) • Streptococcus pneumoniae • Moraxella catarrhalis Respiratory viruses account for around 30% of exacerbations, with the human rhinovirus being the most important pathogen. |
|
How to manage the exacerbation of COPD?
|
• increase frequency of bronchodilator use and consider giving via a nebuliser
• give prednisolone 30 mg daily for 7-14 days it is common practice for all patients with an exacerbation of COPD to receive antibiotics. NICE do not support this approach. They recommend giving oral antibiotics 'if sputum is purulent or there are clinical signs of pneumonia' |
|
What is the management of stable COPD?
|
General management
• smoking cessation advice • annual influenza vaccination • one-off pneumococcal vaccination Bronchodilator therapy • a short-acting beta2-agonist (SABA) or short-acting muscarinic antagonist (SAMA) is first-line treatment • for patients who remain breathless or have exacerbations despite using short-acting bronchodilators the next step is determined by the FEV1 FEV1 > 50% • long-acting beta2-agonist (LABA), for example salmeterol, or: • long-acting muscarinic antagonist (LAMA), for example tiotropium FEV1 < 50% • LABA + inhaled corticosteroid (ICS) in a combination inhaler, or: • LAMA For patients with persistent exacerbations or breathlessness • if taking a LABA then switch to a LABA + ICS combination inhaler • otherwise give a LAMA and a LABA + ICS combination inhaler Oral theophylline • NICE only recommends theophylline after trials of short an long-acting bronchodilators or to people who cannot used inhaled therapy • the dose should be reduced if macrolide or fluoroquinolone antibiotics are co-prescribed Mucolytics • should be 'considered' in patients with a chronic productive cough and continued if symptoms improve |
|
Define cor pulmonale and its management.
|
• features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, loud P2
• use a loop diuretic for oedema, consider long-term oxygen therapy • ACE-inhibitors, calcium channel blockers and alpha blockers are not recommended by NICE |
|
What are the factors that may increase the survival in patients with COPD?
|
• smoking cessation - the single most important intervention in patients who are still smoking
• long term oxygen therapy in patients who fit criteria • lung volume reduction surgery in selected patients |
|
Define cystic fibrosis.
|
Cystic fibrosis (CF) is an autosomal recessive disorder causing increased viscosity of secretions (e.g. lungs and pancreas). It is due to a defect in the cystic fibrosis transmembrane conductance regulator gene (CFTR), which codes a cAMP-regulated chloride channel
In the UK 80% of CF cases are due to delta F508 on the long arm of chromosome 7. Cystic fibrosis affects 1 per 2500 births, and the carrier rate is c. 1 in 25 |
|
What are the organisms which may colonise in CF patients?
|
• Staphylococcus aureus
• Pseudomonas aeruginosa • Burkholderia cepacia* • Aspergillus *previously known as Pseudomonas cepacia |
|
What are the clinical features of cystic fibrosis?
|
Presenting features
• neonatal period (around 20%): meconium ileus, less commonly prolonged jaundice • recurrent chest infections (40%) • malabsorption (30%): steatorrhoea, failure to thrive • other features (10%): liver disease Other features of cystic fibrosis • short stature • diabetes mellitus • delayed puberty • rectal prolapse (due to bulky stools) • nasal polyps • male infertility, female subfertility |
|
What is the management of cystic fibrosis?
|
Management of cystic fibrosis involves a multidisciplinary approach
Key points • regular (at least twice daily) chest physiotherapy and postural drainage. Parents are usually taught to do this. Deep breathing exercises are also useful • high calorie diet, including high fat intake* • vitamin supplementation • pancreatic enzyme supplements taken with meals • heart and lung transplant *this is now the standard recommendation - previously high calorie, low-fat diets have been recommended to reduce the amount of steatorrhoea |
|
What drugs can cause lung fibrosis?
|
Causes
• amiodarone • cytotoxic agents: busulphan, bleomycin • anti-rheumatoid drugs: methotrexate, sulfasalazine, gold • nitrofurantoin • ergot-derived dopamine receptor agonists (bromocriptine, cabergoline, pergolide) |
|
What are the differential diagnosis of haemoptysis?
|
1. Lung cancer (History of smoking, Symptoms of malignancy: weight loss, anorexia)
2. Pulmonary oedema( Dyspnoea, Bibasal crackles and S3 are the most reliable signs) 3. Tuberculosis (Fever, night sweats, anorexia, weight loss) 4. Pulmonary embolism (Pleuritic chest pain,Tachycardia, tachypnoea) 5. Lower respiratory tract infection (Usually acute history of purulent cough) 6. Bronchiectasis (Usually long history of cough and daily purulent sputum production) 7. Mitral stenosis( Dyspnoea, Atrial fibrillation, Malar flush on cheeks, Mid-diastolic murmur) 8. Aspergilloma (Often past history of tuberculosis, Haemoptysis may be severe, Chest x-ray shows rounded opacity ) 9. Wegener's granulomatosis (Upper respiratory tract: epistaxis, sinusitis, nasal crusting, Lower respiratory tract: dyspnoea, haemoptysis, Glomerulonephritis, Saddle-shape nose deformity ) 10. Goodpasture's syndrome (Haemoptysis Systemically unwell: fever, nausea Glomerulonephritis) |
|
Explain influenza vaccination.
|
Seasonal influenza still accounts for a significant morbidity and mortality in the UK each winter, with the influenza season typically starting in the middle of November. This may vary year from year so it is recommended that vaccination occurs between September and early November. There are three types of influenza virus; A, B and C. Types A and B account for the majority of clinical disease. Current vaccines are trivalent and consist of two subtypes of influenza A and one subtype of influenza B.
• it is an inactivated vaccine, so cannot cause influenza. A minority of patients however develop fever and malaise which may last 1-2 days • should be stored between +2 and +8�C and shielded from light • contraindications include hypersensitivity to egg protein. • in adults the vaccination is around 75% effective, although this figure decreases in the elderly • it takes around 10-14 days after immunisation before antibody levels are at protective levels |
|
Who should have annual influenza vaccination?
|
The Department of Health recommends annual influenza vaccination for people older than 65 years and those older than 6 months if they have:
• chronic respiratory disease (including asthmatics who use inhaled steroids) • chronic heart disease (heart failure, ischaemic heart disease, including hypertension if associated with cardiac complications) • chronic kidney disease • chronic liver disease: cirrhosis, biliary atresia, chronic hepatitis • chronic neurological disease: (e.g. Stroke/TIAs) • diabetes mellitus (including diet controlled) • immunosuppression due to disease or treatment (e.g. HIV) • asplenia or splenic dysfunction • pregnant women Other at risk individuals include: • health and social care staff directly involved in patient care (e.g. NHS staff) • those living in long-stay residential care homes • carers of the elderly or disabled person whose welfare may be at risk if the carer becomes ill (at the GP's discretion) Children in at risk groups should be vaccinated. Only children aged less than 9 years who have not received influenza vaccine before should receive a second dose of vaccine at least 4 weeks later. |
|
Who should be considered for immediate referral for patients with suspected cancer?
|
Consider immediate referral for patients with:
• signs of superior vena caval obstruction (swelling of the face/neck with fixed elevation of jugular venous pressure) • stridor |
|
Who should be considered for urgent referral for patients with suspected cancer?
|
• persistent haemoptysis (in smokers or ex-smokers aged 40 years and older)
• a chest X-ray suggestive of lung cancer (including pleural effusion and slowly resolving consolidation) • a normal chest X-ray where there is a high suspicion of lung cancer • a history of asbestos exposure and recent onset of chest pain, shortness of breath or unexplained systemic symptoms |
|
who should be receive urgent CXR?
|
• haemoptysis
• unexplained or persistent (longer than 3 weeks): chest and/or shoulder pain, dyspnoea, weight loss, chest signs, hoarseness, finger clubbing, cervical or supraclavicular lymphadenopathy, cough, features suggestive of metastasis from a lung cancer (for example, secondaries in the brain, bone, liver, skin) • underlying chronic respiratory problems with unexplained changes in existing symptoms |
|
What are the risk factors of lung cancer?
|
Smoking
• increases risk of lung ca by a factor of 10 Other factors • asbestos - increases risk of lung ca by a factor of 5 • arsenic • radon • nickel • chromate • aromatic hydrocarbon • cryptogenic fibrosing alveolitis Factors that are NOT related • coal dust Smoking and asbestos are synergistic, i.e. a smoker with asbestos exposure has a 10 * 5 = 50 times increased risk |
|
Define mycoplasma pneumoniae.
|
Mycoplasma pneumoniae is a cause of atypical pneumonia which often affects younger patients. It is associated with a number of characteristic complications such as erythema multiforme and cold autoimmune haemolytic anaemia. Epidemics of Mycoplasma pneumoniae classically occur every 4 years. It is important to recognise atypical pneumonias as they may not respond to penicillins or cephalosporins
|
|
What are the clinical features and complications of mycoplasma pneumoniae?
|
Features
• the disease typically has a prolonged and gradual onset • flu-like symptoms classically precede a dry cough • bilateral consolidation on x-ray • complications may occur as below Complications • cold agglutins (IgM) may cause an haemolytic anaemia, thrombocytopenia • erythema multiforme, erythema nodosum • meningoencephalitis, Guillain-Barre syndrome • bullous myringitis: painful vesicles on the tympanic membrane • pericarditis/myocarditis • gastrointestinal: hepatitis, pancreatitis • renal: acute glomerulonephritis |
|
What is the investigation of mycoplasma pneumoniae?
|
• diagnosis is generally by Mycoplasma serology
• positive cold agglutination test |
|
What is the management of mycoplasma pneumoniae?
|
• erythromycin/clarithromycin
• tetracyclines such as doxycycline are an alternative |
|
What organisms cause community acquired pneumonia?
|
• Streptococcus pneumoniae (accounts for around 80% of cases)
• Haemophilus influenzae • Staphylococcus aureus: commonly after the 'flu • atypical pneumonias (e.g. Due to Mycoplasma pneumoniae) • viruses Klebsiella pneumoniae is classically in alcoholics |
|
What are the clinical features of community acquired pneumonia?
|
Characteristic features of pneumococcal pneumonia
• rapid onset • high fever • pleuritic chest pain • herpes labialis |
|
What is the management of community acquired pneumonia?
|
The British Thoracic Society published guidelines in 2009:
• low or moderate severity CAP: oral amoxicillin. A macrolide should be added for patients admitted to hospital • high severity CAP: intravenous co-amoxiclav + clarithromycin OR cefuroxime + clarithromycin OR cefotaxime + clarithromycin |
|
What is the management of pulmonary embolism?
|
Low molecular weight heparin (LMWH) or fondaparinux should be given initially after a PE is diagnosed. An exception to this is for patients with a massive PE where thrombolysis is being considered. In such a situation unfractionated heparin should be used.
• a vitamin K antagonist (i.e. warfarin) should be given within 24 hours of the diagnosis • the LMWH or fondaparinux should be continued for at least 5 days or until the international normalised ratio (INR) is 2.0 or above for at least 24 hours, whichever is longer, i.e. LMWH or fondaparinux is given at the same time as warfarin until the INR is in the therapeutic range • warfarin should be continued for at least 3 months. At 3 months, NICE advise that clinicians should 'assess the risks and benefits of extending treatment' • NICE advise extending warfarin beyond 3 months for patients with unprovoked PE. This essentially means that if there was no obvious cause or provoking factor (surgery, trauma, significant immobility) it may imply the patient has a tendency to thrombosis and should be given treatment longer than the norm of 3 months • for patients with active cancer NICE recommend using LMWH for 6 months Thrombolysis • thrombolysis is now recommended as the first-line treatment for massive PE where there is circulatory failure (e.g. hypotension). Other invasive approaches should be considered where appropriate facilities exist |
|
Define obstructive lung disease and give examples of condition.
|
FEV1 - significantly reduced
FVC - reduced or normal FEV1% (FEV1/FVC) - reduced Asthma COPD Bronchiectasis Bronchiolitis obliterans |
|
Define restrictive lung disease and give examples of condition.
|
FEV1 - reduced
FVC - significantly reduced FEV1% (FEV1/FVC) - normal or increased Pulmonary fibrosis Asbestosis Sarcoidosis Acute respiratory distress syndrome Infant respiratory distress syndrome Kyphoscoliosis Neuromuscular disorders |
|
respiratory syncytial virus causes...
|
bronchiolitis
|
|
parainfluenza virus causes...
|
croup
|
|
rhinovirus causes...
|
common cold
|
|
influenza virus causes...
|
flu
|
|
Streptococcus pneumoniae causes...
|
The most common cause of community-acquired pneumonia
|
|
Haemophilus influenzae causes...
|
Community-acquired pneumonia
Most common cause of bronchiectasis exacerbations Acute epiglottitis |
|
Staphylococcus aureus causes...
|
Pneumonia, particularly following influenza
|
|
Mycoplasma pneumoniae causes...
|
Atypical pneumonia
Flu-like symptoms classically precede a dry cough. Complications include haemolytic anaemia and erythema multiform |
|
Legionella pneumophilia causes...
|
Atypical pneumonia
Classically spread by air-conditioning systems, causes dry cough. Lymphopenia, deranged liver function tests and hyponatraemia may be seen |
|
Pneumocystis jiroveci causes...
|
Common cause of pneumonia in HIV patients. Typically patients have few chest signs and develop exertional dyspnoea
|
|
Mycobacterium tuberculosis causes...
|
Causes tuberculosis. A wide range of presentations from asymptomatic to disseminated disease are possible. Cough, night sweats and weight loss may be seen
|
|
What are the respiratory problems of rheumatoid arthritis?
|
A variety of respiratory problems may be seen in patients with rheumatoid arthritis:
• pulmonary fibrosis • pleural effusion • pulmonary nodules • bronchiolitis obliterans • complications of drug therapy e.g. methotrexate pneumonitis • pleurisy • Caplan's syndrome - massive fibrotic nodules with occupational coal dust exposure • infection (possibly atypical) secondary to immunosuppression |
|
What conditions cause chronic SOB?
|
1. Chronic obstructive pulmonary disease ( Seen invariably in smokers, Chronic productive cough is typical, Features of right heart failure may be seen)
2. Heart failure (A history of ischaemic heart disease or hypertension may be present, Orthopnoea and paroxysmal nocturnal dyspnoea are characteristic, Bibasal crackles and a third heart sound (S3) are the most reliable features of left-sided failure, Right heart failure causes peripheral oedema and a raised JVP) 3. Asthma ( Cough, wheeze and shortness of breath are typical, Symptoms are often worse at night and may be precipitated by cold weather or exercise, Associated with hay fever and eczema) 4. Aortic stenosis (Chest pain, SOB and syncope seen in symptomatic patients, An ejection systolic murmur radiating to the neck and narrow pulse pressure are found on examination) 5.Recurrent pulmonary emboli (There may be a history of predisposing factors e.g. Malignancy, Pleuritic chest pain and haemoptysis may be seen but symptoms are often vague, Tachycardia and tachypnoea are common in the acute situation, Symptoms of right heart failure may develop in severe cases) 6. Lung cancer ( Normally seen in smokers,Haemoptysis, chronic cough or unresolving infection are common presentations, Systemic symptoms e.g. Weight loss and anorexia) 7. Pulmonary fibrosis (Progressive shortness of breath may be the only symptom, Fine bibasal crackles are typical Spirometry shows a restrictive pattern) 8. Bronchiectasis ( Affected patients may produce large amounts of purulent sputum, Patients may have a history of previous infections (e.g. Tuberculosis, measles), bronchial obstruction or ciliary dyskinetic syndromes e.g. Kartagener's syndrome) 9. Anaemia (There may be a history of gastrointestinal symptoms, Pallor may be seen on examination) 10. Obesity ( Obese patients tend to be more SOB due to the increased work of activity) |
|
Define antiphospholipid syndrome
|
Antiphospholipid syndrome is an acquired disorder characterised by a predisposition to both venous and arterial thromboses, recurrent fetal loss and thrombocytopenia. It may occur as a primary disorder or secondary to other conditions, most commonly systemic lupus erythematosus (SLE)
|
|
What are the clinical features of antiphospholipid syndrome.
|
Features
• venous/arterial thrombosis • recurrent fetal loss • livedo reticularis • thrombocytopenia • prolonged APTT • other features: pre-eclampsia, pulmonary hypertension |
|
What conditions are associated with SLE?
|
Associations other than SLE
• other autoimmune disorders • lymphoproliferative disorders • phenothiazines (rare) |
|
What is the management of antiphospholipid syndrome?
|
Management - based on BCSH guidelines
• initial venous thromboembolic events: evidence currently supports use of warfarin with a target INR of 2-3 for 6 months • recurrent venous thromboembolic events: lifelong warfarin; if occurred whilst taking warfarin then increase target INR to 3-4 • arterial thrombosis should be treated with lifelong warfarin with target INR 2-3 |
|
What are the complications of antiphophopid syndrome during pregnancy
|
In pregnancy the following complications may occur:
• recurrent miscarriage • IUGR • pre-eclampsia • placental abruption • pre-term delivery • venous thromboembolism |
|
What is the management of pregnant women with antiphopholipid syndrome?
|
• low-dose aspirin should be commenced once the pregnancy is confirmed on urine testing
• low molecular weight heparin once a fetal heart is seen on ultrasound. This is usually discontinued at 34 weeks gestation • these interventions increase the live birth rate seven-fold |
|
Define chronic lymphocytic leukaemia.
|
Chronic lymphocytic leukaemia (CLL) is caused by a monoclonal proliferation of well-differentiated lymphocytes which are almost always B-cells (99%)
|
|
What are the clinical features and complication of chronic lymphocytic leukaemia?
|
Features
• often none • constitutional: anorexia, weight loss • bleeding, infections • lymphadenopathy more marked than CML Complications • hypogammaglobulinaemia leading to recurrent infections • warm autoimmune haemolytic anaemia in 10-15% of patients • transformation to high-grade lymphoma (Richter's transformation) |
|
What are the investigations for suspected chronic lymphocytic leukaemia?
|
Investigations
• blood film: smudge cells • immunophenotyping |
|
Which score should be done on patients with suspected DVT?
|
2 level DVT wells score
|
|
What is the 2 level DVT wells score?
|

     Active cancer (treatment ongoing, within 6 months, or palliative) -1 Paralysis, paresis or recent plaster immobilisation of the lower extremities -1  Recently bedridden for 3 days or more or major surgery within 12 weeks requiring general or regional anaesthesia -1 Localised tenderness along the distribution of the deep venous system - 1 Entire leg swollen -1  Calf swelling at least 3 cm larger than asymptomatic side -1 Pitting oedema confined to the symptomatic leg- 1  Collateral superficial veins (non-varicose) -1 Previously documented DVT -1 An alternative diagnosis is at least as likely as DVT − minus 2  Clinical probability simplified score • DVT likely: 2 points or more • DVT unlikely: 1 point or less  |
|
What the management of DVT wells score greater than 2 points?
|
If a DVT is 'likely' (2 points or more)
• a proximal leg vein ultrasound scan should be carried out within 4 hours and, if the result is negative, a D-dimer test • if a proximal leg vein ultrasound scan cannot be carried out within 4 hours a D-dimer test should be performed and low-molecular weight heparin administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours) |
|
What is the management of DVT wells score less than or equal to 1?
|
If a DVT is 'unlikely' (1 point or less)
• perform a D-dimer test and if it is positive arrange: • a proximal leg vein ultrasound scan within 4 hours • if a proximal leg vein ultrasound scan cannot be carried out within 4 hours low-molecular weight heparin should be administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours) |
|
What is the management of confirmed DVT?
|
Low molecular weight heparin (LMWH) or fondaparinux should be given initially after a DVT is diagnosed.
• a vitamin K antagonist (i.e. warfarin) should be given within 24 hours of the diagnosis • the LMWH or fondaparinux should be continued for at least 5 days or until the international normalised ratio (INR) is 2.0 or above for at least 24 hours, whichever is longer, i.e. LMWH or fondaparinux is given at the same time as warfarin until the INR is in the therapeutic range • warfarin should be continued for at least 3 months. At 3 months, NICE advise that clinicians should 'assess the risks and benefits of extending treatment' • NICE add 'consider extending warfarin beyond 3 months for patients with unprovoked proximal DVT if their risk of VTE recurrence is high and there is no additional risk of major bleeding'. This essentially means that if there was no obvious cause or provoking factor (surgery, trauma, significant immobility) it may imply the patient has a tendency to thrombosis and should be given treatment longer than the norm of 3 months • for patients with active cancer NICE recommend using LMWH for 6 months |
|
Define G6PD deficiency.
|
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest red blood cell enzyme defect. It is more common in people from the Mediterranean and Africa and is inherited in a X-linked recessive fashion.
|
|
What are the clinical features of G6PD deficiency?
|
Features
• neonatal jaundice is often seen • intravascular haemolysis- anaeia • gallstones are common • splenomegaly may be present • Heinz bodies on blood films |
|
How is G6PD deficiency diagnosed?
|
Diagnosis is made by using a G6PD enzyme assay
|
|
What exacerbate a crisis of G6PD deficiency?
|
Many drugs can precipitate a crisis as well as infections and broad (fava) beans.
Some drugs causing haemolysis • anti-malarials: primaquine • ciprofloxacin • sulphonamides |
|
What medications were taught to be safe in G6PD deficiency?
|
Some drugs thought to be safe
• penicillins • cephalosporins • macrolides • tetracyclines • trimethoprim |
|
Define hereditary spherocytosis.
|
Basics
• most common hereditary haemolytic anaemia in people of northern European descent • autosomal dominant defect of red blood cell cytoskeleton • the normal biconcave disc shape is replaced by a sphere-shaped red blood cell • red blood cell survival reduced as destroyed by the spleen |
|
Clinical features of hereditary spherocytosis.
|
• failure to thrive
• jaundice, gallstones • splenomegaly • aplastic crisis precipitated by parvovirus infection • degree of haemolysis variable |
|
Investigation of hereditary spherocytosis.
|
• osmotic fragility test
|
|
What is the management of hereditary spherocytosis?
|
Management
• folate replacement • splenectomy |
|
Define ITP.
|
Idiopathic thrombocytopenic purpura (ITP) is an immune mediated reduction in the platelet count. Antibodies are directed against the glycoprotein IIb/IIIa or Ib-V-IX complex.
|
|
How can ITP be divided?
|
ITP can be divided into acute and chronic forms:
Acute ITP • more commonly seen in children • equal sex incidence • may follow an infection or vaccination • usually runs a self-limiting course over 1-2 weeks Chronic ITP • more common in young/middle-aged women • tends to run a relapsing-remitting course |
|
Define evan's syndrome.
|
Evan's syndrome
• ITP in association with autoimmune haemolytic anaemia (AIHA) |
|
Causes of generalised lymphadenopathy.
|
There are many causes of generalised lymphadenopathy
Infective • infectious mononucleosis • HIV, including seroconversion illness • eczema with secondary infection • rubella • toxoplasmosis • CMV • tuberculosis • roseola infantum Neoplastic • leukaemia • lymphoma Others • autoimmune conditions: SLE, rheumatoid arthritis • graft versus host disease • sarcoidosis • drugs: phenytoin and to a lesser extent allopurinol, isoniazid |
|
How can macrocytic anaemia be divided?
|
Macrocytic anaemia can be divided into causes associated with a megaloblastic bone marrow and those with a normoblastic bone marrow
|
|
What are the causes of megaloblastic macrocytic anaemia?
|
• vitamin B12 deficiency
• folate deficiency |
|
What are the causes of normoblastic macrocytic anaemia?
|
• alcohol
• liver disease • hypothyroidism • pregnancy • reticulocytosis e.g. haemolysis • myelodysplasia • drugs: cytotoxics |
|
Define polycythaemia. How can polycythaemia be divided?
|
Polycythaemia may be relative, primary (polycythaemia rubra vera) or secondary
Relative causes • dehydration • stress: Gaisbock syndrome Primary • polycythaemia rubra vera Secondary causes • COPD • altitude • obstructive sleep apnoea • excessive erythropoietin: cerebellar haemangioma, hypernephroma, hepatoma, uterine fibroids* To differentiate between true (primary or secondary) polycythaemia and relative polycythaemia red cell mass studies are sometimes used. In true polycythaemia the total red cell mass in males > 35 ml/kg and in women > 32 ml/kg *uterine fibroids may cause menorrhagia which in turn leads to blood loss - polycythaemia is rarely a clinical problem |
|
What are the risk factors of venous thromboembolism?
|
Common predisposing factors include malignancy, pregnancy and the period following an operation. The comprehensive list below is partly based on the 2010 SIGN venous thromboembolism (VTE) guidelines:
General • increased risk with advancing age • obesity • family history of VTE • pregnancy (especially puerperium) • immobility • hospitalisation • anaesthesia • central venous catheter: femoral >> subclavian Underlying conditions • malignancy • thrombophilia: e.g. Activated protein C resistance, protein C and S deficiency • heart failure • antiphospholipid syndrome • Behcet's • polycythaemia • nephrotic syndrome • sickle cell disease • paroxysmal nocturnal haemoglobinuria • hyperviscosity syndrome • homocystinuria Medication • combined oral contraceptive pill: 3rd generation more than 2nd generation • hormone replacement therapy • raloxifene and tamoxifen • antipsychotics (especially olanzapine) have recently been shown to be a risk factor SIGN also state that the following are risk factors for recurrent VTE: • previous unprovoked VTE • male sex • obesity • thrombophilias |
|
What is warfarin?
|
Warfarin is an oral anticoagulant which inhibits the reduction of vitamin K to its active hydroquinone form, which in turn acts as a cofactor in the carboxylation of clotting factor II, VII, IX and X (mnemonic = 1972) and protein C.
|
|
What are the indications of warfarin?
|
• venous thromboembolism: target INR = 2.5, if recurrent 3.5
• atrial fibrillation, target INR = 2.5 • mechanical heart valves, target INR depends on the valve type and location. Mitral valves generally require a higher INR than aortic valves. |
|
What factor may potentiate warfarin?
|
Factors that may potentiate warfarin
• liver disease • P450 enzyme inhibitors, e.g.: amiodarone, ciprofloxacin • cranberry juice • drugs which displace warfarin from plasma albumin, e.g. NSAIDs • inhibit platelet function: NSAIDs |
|
What are the side effects of warfarin?
|
• haemorrhage
• teratogenic, although can be used in breast-feeding mothers • skin necrosis: when warfarin is first started biosynthesis of protein C is reduced. This results in a temporary procoagulant state after initially starting warfarin, normally avoided by concurrent heparin administration. Thrombosis may occur in venules leading to skin necrosis • purple toes |
|
What is the management of INR > 8 with minor bleeding and > 8 without bleeding?
|
1. INR > 8.0 Minor bleeding
Stop warfarin Give intravenous vitamin K 1-3mg Repeat dose of vitamin K if INR still too high after 24 hours Restart warfarin when INR < 5.0 2. INR > 8.0 No bleeding Stop warfarin Give vitamin K 1-5mg by mouth, using the intravenous preparation orally Repeat dose of vitamin K if INR still too high after 24 hours Restart when INR < 5.0 |
|
What is the management of INR > 5 with minor bleeding and > 5 without bleeding?
|
1.INR 5.0-8.0 Minor bleeding
Stop warfarin Give intravenous vitamin K 1-3mg Restart when INR < 5.0 2. INR 5.0-8.0 No bleeding Withhold 1 or 2 doses of warfarin Reduce subsequent maintenance dose |
|
What is the management of major INR related bleeding?
|
Stop warfarin
Give intravenous vitamin K 5mg Prothrombin complex concentrate - if not available then FFP* *as FFP can take time to defrost prothrombin complex concentrate should be considered in cases of intracranial haemorrhage |
|
What tumours cause bone metastases?
|
Most common tumour causing bone metastases (in descending order)
• prostate • breast • lung Most common site (in descending order) • spine • pelvis • ribs • skull • long bones |
|
What is the NICE guideline regarding referral for suspected breast cancer?
|
Urgent referrals (i.e. within 2 weeks)
• any breast lump with features suggestive of cancer (hard, tethered etc) • any breast lump in a post-menopausal woman, regardless of features suggestive of cancer • any breast lump in a women more than 30 years old without features suggestive of cancer but which persists after her next period • if there is past history of breast cancer any breast lump should warrant urgent referral • spontaneous unilateral bloody nipple discharge • unilateral eczematous skin or nipple change that does not respond to topical treatment, or with nipple distortion of recent onset Non-urgent referrals • women < 30 years old who present with a breast lump with no features suggestive of cancer, no relevant family history and no change in the size of the lump |
|
What is the top ten causes of cancer in the UK ? ( commonest -> least)
|
• 1. Breast
• 2. Lung • 3. Colorectal • 4. Prostate • 5. Bladder • 6. Non-Hodgkin's lymphoma • 7. Melanoma • 8. Stomach • 9. Oesophagus • 10. Pancreas *excludes non-melanoma skin cancer |
|
What is the top ten causes of death in the UK? ( commonest-> least)
|
The most common causes of death from cancer in the UK are as follows:
• 1. Lung • 2. Colorectal • 3. Breast • 4. Prostate • 5. Pancreas • 6. Oesophagus • 7. Stomach • 8. Bladder • 9. Non-Hodgkin's lymphoma • 10. Ovarian |
|
Explain cervical cancer and its clinical features.
|
The incidence of cervical cancer peaks around the 6th decade. It may be divided into
• squamous cell cancer (80%) • adenocarcinoma (20%) Features • may be detected during routine cervical cancer screening • abnormal vaginal bleeding: postcoital, intermenstrual or postmenopausal bleeding • vaginal discharge Risk factors • human papilloma virus 16,18 & 33 • smoking • human immunodeficiency virus • early first intercourse, many sexual partners • high parity • lower socioeconomic status • combined oral contraceptive pill* *the strength of this association is sometimes debated but a large study published in the Lancet (2007 Nov 10;370(9599):1609-21) confirmed the link |
|
Explain chemotherapy side effects: nausea and vomiting.
|
Nausea and vomiting are common side-effects of chemotherapy. Risk factors for the development of symptoms include:
• anxiety • age less than 50 years old • concurrent use of opioids • the type of chemotherapy used For patients at low-risk of symptoms then drugs such as metoclopramide may be used first-line. For high-risk patients then 5HT3 receptor antagonists such as ondansetron are often effective, especially if combined with dexamethasone |
|
Explain chronic lymphocytic leukaemia and its clinical features/complications/ investigation.
|
Chronic lymphocytic leukaemia (CLL) is caused by a monoclonal proliferation of well-differentiated lymphocytes which are almost always B-cells (99%)
Features • often none • constitutional: anorexia, weight loss • bleeding, infections • lymphadenopathy more marked than CML Complications • hypogammaglobulinaemia leading to recurrent infections • warm autoimmune haemolytic anaemia in 10-15% of patients • transformation to high-grade lymphoma (Richter's transformation) Investigations • blood film: smudge cells • immunophenotyping |
|
Which patients should be referred urgently ( ie. < 2 weeks) rule to colorectal services for investigation?
|
• patients > 40 years old, reporting rectal bleeding with a change of bowel habit towards looser stools and/or increased stool frequency persisting for 6 weeks or more
• patients > 60 years old, with rectal bleeding persisting for 6 weeks or more without a change in bowel habit and without anal symptoms • patients > 60 years old, with a change in bowel habit to looser stools and/or more frequent stools persisting for 6 weeks or more without rectal bleeding • any patient presenting with a right lower abdominal mass consistent with involvement of the large bowel • any patient with a palpable rectal mass • unexplained iron deficiency anaemia in men or non-menstruating women (Hb < 11 g/dl in men, < 10 g/dl in women) |
|
What is the colorectal cancer screening?
|
Overview
• most cancers develop from adenomatous polyps. Screening for colorectal cancer has been shown to reduce mortality by 16% • the NHS now has a national screening programme offering screening every 2 years to all men and women aged 60 to 69 years. Patients aged over 70 years may request screening • eligible patients are sent faecal occult blood (FOB) tests through the post • patients with abnormal results are offered a colonoscopy At colonoscopy, approximately: • 5 out of 10 patients will have a normal exam • 4 out of 10 patients will be found to have polyps which may be removed due to their premalignant potential • 1 out of 10 patients will be found to have cancer |
|
MOA, Adverse effects, class:Cyclophosphamide
|
Alkylating agent - causes cross-linking in DNA
Side effect: Haemorrhagic cystitis, myelosuppression, transitional cell carcinoma |
|
MOA, Adverse effects, class: Bleomycin
|
Cytotoxic antibiotics
Degrades preformed DNA S/E: Lung fibrosis |
|
MOA, Adverse effects, class: Doxorubicin
|
Cytotoxic antibiotics
Stabilizes DNA-topoisomerase II complex inhibits DNA & RNA synthesis S/E: Cardiomyopathy |
|
MOA, Adverse effects, class:Methotrexate
|
Inhibits dihydrofolate reductase and thymidylate synthesis
S/E: Myelosuppression, mucositis, liver fibrosis, lung fibrosis |
|
MOA, Adverse effects, class:Fluorouracil (5-FU)
|
Pyrimidine analogue inducing cell cycle arrest and apoptosis by blocking thymidylate synthase (works during S phase)
S/E: Myelosuppression, mucositis, dermatitis |
|
MOA, Adverse effects, class: 6-mercaptopurine
|
Purine analogue that is activated by HGPRTase, decreasing purine synthesis
S/E: Myelosuppression |
|
MOA, Adverse effects, class:Vincristine, vinblastine
|
Acts on microtubules
Inhibits formation of microtubules S/E: Vincristine: Peripheral neuropathy (reversible) , paralytic ileus S/E: Vinblastine: myelosuppression |
|
MOA, Adverse effects, class: Docetaxel
|
Acts on microtubules
Prevents microtubule depolymerisation & disassembly, decreasing free tubulin S/E: Neutropaenia |
|
MOA, Adverse effects, class: Cisplatin
|
Causes cross-linking in DNA
S/E: Ototoxicity, peripheral neuropathy, hypomagnesaemia |
|
MOA, Adverse effects, class: Hydroxyurea (hydroxycarbamide)
|
Inhibits ribonucleotide reductase, decreasing DNA synthesis
S/E: Myelosuppression |
|
Explain endometrial cancer.
|
Endometrial cancer is classically seen in post-menopausal women but around 25% of cases occur before the menopause. It usually carries a good prognosis due to early detection
|
|
What are the risk factors of endometrial cancer?
|
The risk factors for endometrial cancer are as follows*:
• obesity • nulliparity • late menopause • unopposed oestrogen. The addition of a progestogen to oestrogen reduces this risk (e.g. In HRT). The BNF states that the additional risk is eliminated if a progestogen is given continuously • diabetes mellitus • tamoxifen • polycystic ovarian syndrome |
|
What are the clinical features of endometrial cancer?
|
• post-menopausal bleeding is the classic symptom
• pre-menopausal women may have a change intermenstrual bleeding • pain and discharge are unusual features |
|
Investigation of endometrial cancer.
|
• first-line investigation is trans-vaginal ultrasound - a normal endometrial thickness (< 4 mm) has a high negative predictive value
• hysteroscopy with endometrial biopsy |
|
Management of endometrial cancer.
|
• localised disease is treated with total abdominal hysterectomy with bilateral salpingo-oophorectomy. Patients with high-risk disease may have post-operative radiotherapy
• progestogen therapy is sometimes used in frail elderly women not consider suitable for surgery |
|
What is protective to endometrial cancer?
|
COCP
|
|
What is the epidemiology of gastric cancer?
|
• overall incidence is decreasing, but incidence of tumours arising from the cardia is increasing
• peak age = 70-80 years • more common in Japan, China, Finland and Colombia than the West • more common in males, 2:1 |
|
What is gastric cancer associated with?
|
Associations
• H. pylori infection • blood group A: gAstric cAncer • gastric adenomatous polyps • pernicious anaemia • smoking • diet: salty, spicy, nitrates • may be negatively associated with duodenal ulcer |
|
Investigation of gastric cancer
|
• diagnosis: endoscopy with biopsy
• staging: CT or endoscopic ultrasound - endoscopic ultrasound has recently been shown to be superior to CT |
|
Explain oesophageal cancer
|
Until recent times oesophageal cancer was most commonly due to a squamous cell carcinoma but the incidence of adenocarcinoma is rising rapidly. Adenocarcinoma is now the most common type of oesophageal cancer and is more likely to develop in patients with a history of gastro-oesophageal reflux disease (GORD) or Barrett's.
The majority of tumours are in the middle third of the oesophagus. |
|
What are the risk factors of oesophageal cancer?
|
Risk factors
• smoking • alcohol • GORD • Barrett's oesophagus • achalasia • Plummer-Vinson syndrome • rare: coeliac disease, scleroderma |
|
Explain ovarian cancer.
|
Ovarian cancer is the fifth most common malignancy in females. The peak age of incidence is 60 years and it generally carries a poor prognosis due to late diagnosis. Around 90% of ovarian cancers are epithelial in origin
|
|
What are the risk factors of ovarian cancer?
|
Risk factors
• family history: mutations of the BRCA1 or the BRCA2 gene • many ovulations: early menarche, late menopause, nulliparity It is traditionally taught that infertility treatment increases the risk of ovarian cancer, as it increases the number of ovulations. Recent evidence however suggests that there is not a significant link. The combined oral contraceptive pill reduces the risk (fewer ovulations) as does having many pregnancies. |
|
clinical features of ovarian cancer?
|
Clinical features are notoriously vague
• abdominal distension and bloating • abdominal and pelvic pain • urinary symptoms e.g. Urgency • early satiety • diarrhoea Diagnosis is difficult and usually involves diagnostic laparotomy |
|
Palliative care prescribing: agitation and confusion
|
Underlying causes of confusion need to be looked for and treated as appropriate, for example hypercalcaemia, infection, urinary retention and medication. If specific treatments fail then the following may be tried:
• first choice: haloperidol • other options: chlorpromazine, levomepromazine In the terminal phase of the illness (for example a patient on the Care of the Dying pathway) then agitation or restlessness is best treated with midazolam |
|
Palliative care prescribing: hiccups
|
Management of hiccups
• chlorpromazine is licensed for the treatment of intractable hiccups • haloperidol, gabapentin and baclofen are also used |
|
What is the NICE guideline in use of opioids in palliative care patients?
|
Starting treatment
• when starting treatment, offer patients with advanced and progressive disease regular oral modified-release (MR) or oral immediate-release morphine (depending on patient preference), with oral immediate-release morphine for breakthrough pain • if no comorbidities use 20-30mg of MR a day with 5mg morphine for breakthrough pain. For example, 15mg modified-release morphine tablets twice a day with 5mg of oral morphine solution as required • oral modified-release morphine should be used in preference to transdermal patches • laxatives should be prescribed for all patients initiating strong opioids • patients should be advised that nausea is often transient. If it persists then an antiemetic should be offered |
|
What is the SIGN guideline on the control of pain in adult with cancer?
|
• the breakthrough dose of morphine is one-sixth the daily dose of morphine
• all patients who receive opioids should be prescribed a laxative • opioids should be used with caution in patients with chronic kidney disease. Alfentanil, buprenorphine and fentanyl are preferred • metastatic bone pain may respond to NSAIDs, bisphosphonates or radiotherapy |
|
How many percent should the next dose of opioids be increased by in palliative care patients?
|
When increasing the dose of opioids the next dose should be increased by 30-50%.
|
|
What are the side effects of opioid ?
|
transient- nausea and drowsiness
persistent- constipation |
|
What is the conversion between oral codeine to oral morphine?
|
divide by 10
|
|
What is the conversion between oral tramadol to oral morphine?
|
divide by 5
|
|
What is the conversion between oral morphine to oral oxycodone?
|
divide by 2
|
|
What does 12 microgram transdermal fentayl patch equate to oral morphine daily?
|
• a transdermal fentanyl 12 microgram patch equates to approximately 45 mg oral morphine daily
|
|
what does 20 microgram patch transdermal buprenorphine equate to oral morphine daily?
|
• a transdermal buprenorphine 20 microgram patch equates to approximately 30 mg oral morphine daily.
|
|
What is the conversion factor between oral morphine to subcutaneous diamorphine?
|
divide by 3
|
|
What is the conversion factor between oral oxycodone to subcutaneous diamorphine?
|
divide by 1.5
|
|
What are the treatment options of localised prostate cancer (T1/T2)
|
Treatment depends on life expectancy and patient choice. Options include:
• conservative: active monitoring & watchful waiting • radical prostatectomy • radiotherapy: external beam and brachytherapy |
|
What are the treatment option of localised advanced prostate cancer (T3/T4)?
|
Options include:
• hormonal therapy: see below • radical prostatectomy • radiotherapy: external beam and brachytherapy Synthetic GnRH agonist • e.g. Goserelin (Zoladex) • cover initially with anti-androgen to prevent rise in testosterone Anti-androgen • cyproterone acetate prevents DHT binding from intracytoplasmic protein complexes |
|
what are the treatment options of metastatic prostate cancer disease?
|
1. Hormonal
Synthetic GnRH agonist • e.g. Goserelin (Zoladex) • cover initially with anti-androgen to prevent rise in testosterone Anti-androgen • cyproterone acetate prevents DHT binding from intracytoplasmic protein complexes 2. Orchidectomy |
|
What is the gleason score?
|
The Gleason score is used to predict prognosis in patients with prostatic cancer. The grading system is based on the glandular architecture seen on histology following hollow needle biopsy
The most prevalent and the second most prevalent pattern seen are added to obtain a Gleason score. The Gleason grade ranges from 1 to 5 meaning the Gleason score ranges from 2 to 10 (i.e. two values added) The higher the Gleason score the worse the prognosis |
|
Define spinal cord compression.
|
Spinal cord compression is an oncological emergency and affects up to 5% of cancer patients. Extradural compression accounts for the majority of cases, usually due to vertebral body metastases. It is more common in patients with lung, breast and prostate cancer
|
|
Clinical features of spinal cord compression
|
Features
• back pain - the earliest and most common symptom - may be worse on lying down and coughing • lower limb weakness • sensory changes: sensory loss and numbness • neurological signs depend on the level of the lesion. Lesions above L1 usually result in upper motor neuron signs in the legs and a sensory level. Lesions below L1 usually cause lower motor neuron signs in the legs and perianal numbness. Tendon reflexes tend to be increased below the level of the lesion and absent at the level of the lesion |
|
Management of spinal cord compression
|
• high-dose oral dexamethasone
• urgent oncological assessment for consideration of radiotherapy or surgery |
|
Define superior vena cava obstruction.
|
Superior vena cava (SVC) obstruction is an oncological emergency caused by compression of the SVC. It is most commonly associated with lung cancer.
|
|
Clinical features of superior vena cava obstruction
|
• dyspnoea is the most common symptom
• swelling of the face, neck and arms - conjunctival and periorbital oedema may be seen • headache • visual disturbance • pulseless jugular venous distension |
|
Causes of superior vena cava obstruction
|
• common malignancies: small cell lung cancer, lymphoma
• other malignancies: metastatic seminoma, Kaposi's sarcoma, breast cancer • aortic aneurysm • mediastinal fibrosis • goitre • SVC thrombosis |
|
Management of superior vena cava obstruction
|
• general: dexamethasone, balloon venoplasty, stenting
• small cell: chemotherapy + radiotherapy • non-small cell: radiotherapy |
|
When is syringe driver used?
|
A syringe driver should be considered in the palliative care setting when a patient is unable to take oral medication due to nausea, dysphagia, intestinal obstruction, weakness or coma.
|
|
What are the two main types of syringe drivers in the UK?
|
In the UK there are two main types of syringe driver:
• Graseby MS16A (blue): the delivery rate is given in mm per hour • Graseby MS26 (green): the delivery rate is given in mm per 24 hours |
|
What medications used in syringe drivers are compatible and recommended with 0.9% sodium chloride?
|
• granisetron
• ketamine • ketorolac • octreotide • ondansetron |
|
What are the commonly used drugs in syringe drivers?
|
• nausea and vomiting: cyclizine, levomepromazine, haloperidol, metoclopramide
• respiratory secretions: hyoscine hydrobromide • bowel colic: hyoscine butylbromide • agitation/restlessness: midazolam, haloperidol, levomepromazine • pain: diamorphine is the preferred opioid |
|
In mixing a syringe driver, which drugs are compatible with diamorphine?
|
• diamorphine (the most commonly used drug) is compatible with the majority of other drugs used including cyclizine*, dexamethasone, haloperidol, hyoscine butylbromide, hyoscine hydrobromide, levomepromazine, metoclopramide, midazolam
*precipitation may be seen at higher doses |
|
In mixing a syringe driver, which drugs are incompatible with cyclizine?
|
• cyclizine is incompatible with a number of drugs including clonidine, dexamethasone, hyoscine butylbromide (occasional), ketamine, ketorolac, metoclopramide, midazolam, octreotide, sodium chloride 0.9%
|
|
Define testicular cancer.
|
Testicular cancer is the most common malignancy in men aged 20-30 years. Around 95% of cases of testicular cancer are germ-cell tumours. Germ cell tumours may essentially be divided into:
• seminomas • teratomas Other type of germ cell tumours include yolk sac tumours. Non-germ cell tumours include Leydig cell tumours and sarcomas. The peak incidence for teratomas is 25 years and seminomas is 35 years |
|
What are the risk factors for testicular cancer?
|
Risk factors include:
• cryptorchidism • infertility • family history • Klinefelter's syndrome • mumps orchitis |
|
What are the clinical features of testicular cancer?
|
• a painless lump is the most common presenting symptom
• pain may also be present in a minority of men • other possible features include hydrocele, gynaecomastia |
|
What is the first line investigation for testicular cancer?
|
• ultrasound is first-line
|
|
What is the management of testicular cancer?
|
• orchidectomy
• chemotherapy and radiotherapy may be given depending on staging |
|
What is the prognosis of testicular cancer?
|
Prognosis is generally excellent
• 5 year survival for seminomas is around 95% if Stage I • 5 year survival for teratomas is around 85% if Stage I |
|
How are tumour markers divided?
|
Tumour markers may be divided into:
• monoclonal antibodies against carbohydrate or glycoprotein tumour antigens ( CA 125, CA 19-9, CA 15-3) • tumour antigens ( PSA, AFP, CEA) • enzymes (alkaline phosphatase, neurone specific enolase) • hormones (e.g. calcitonin, ADH) |
|
CA 125
|
Ovarian cancer
|
|
Ca 19-9
|
Pancreatic cancer
|
|
CA 15-3
|
breast cancer
|
|
Prostate specific antigen (PSA)
|
Prostatic carcinoma
|
|
alpha-feto protein ( AFP)
|
Hepatocellular carcinoma, teratoma
|
|
Carcinoembryonic antigen (CEA)
|
Colorectal cancer
|